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3‘Nainen tarvitsee elämässään kahta asiaa: huumoria ja punaiset 
korkokengät. Tohtorintutkinto on hyväksi muttei välttämätön.’ 
[Riikka Pulkkinen: Totta]
4abstract
The human body is protected from invading pathogens and foreign material by its 
immune system. The most common routes for pathogens to enter the human body 
are via inhalation, digestion or dermal penetration. The first stage of protection 
is a layer of epithelial cells forming a physical barrier on the body surfaces. This 
may be accompanied with mucus secretion and special cells, i.e. ciliated cells in the 
lungs and a biochemical barrier i.e. enzymes. These non-specific barriers are part 
of the innate immunity: Rapid and non-specific immune system. Innate immunity 
also possesses specific cells operating in the body surfaces. The most important of 
these cells are phagocytosing cells, which scavenge foreign material in the body 
cavities and secreting signalling molecules to further activate other cells of the 
immune response. Macrophages and dendritic cells are not the only phagocytes 
but they are also able to present antigens to the cells of the adaptive immunity, and 
therefore further activate this specific response against pathogens via T and B cell 
activation. When the immune system functions in its regular manner, it is practically 
invincible, but if there are any imbalances in the response, different outcomes such 
as inflammation and allergic diseases may be induced.
Engineered nanomaterials (ENM) are widely used in the industry. Their unique 
and attractive characteristics are said to improve competitiveness and potential for 
innovations in the different sectors of industry, and it has been estimated that the 
market size of nanotechnological innovations will exceed 2 trillion euros in 2015. 
However, the toxicological hazard and risk assessment of different nanomaterials 
is far from complete. There is some concern that nanomaterials may cause toxic 
outcomes, and more research efforts are now being put into the hazard assessment. 
However, the risk assessment of nanomaterials requires not only information on 
their hazardous properties but also awareness about the risks of exposure, and 
therefore cooperation between different expertise areas is required. In addition, 
the huge amount of differently modified nanomaterials poses a challenge for 
toxicologists who will have to develop new, quicker and cheaper approaches for 
hazard and risk assessment to guarentee the human health.
In this thesis, an immunotoxicological approach was used to compare 
different types of ENM and the effect of size, shape and surface modifications 
on the toxicity of ENM. The results confirm that the materials possess different 
hazardous properties and provide evidence of the mechanisms behind fibre-induced 
inflammation. The studies performed with cell models suggest that different ENM 
induce different responses in antigen presenting cells. Furthermore, the results 
show that surface modifications of metal oxide nanoparticles as well as shape of 
5the carbon nanomaterials drastically influence their toxicity. The mechanistical 
study performed with carbon nanotubes (CNT) in vitro clearly demonstrated that 
long, rigid carbon nanotubes resemble asbestos fibres in their ability to activate the 
NLRP3 inflammasome essential for efficient immune response. The proteomics 
study on the secretomes of the macrophages, which had been exposed with different 
CNT, and asbestos fibres indicated that different shaped CNT can induce different 
responses in macrophages, confirming the finding that not all CNT are identical 
to asbestos fibres. In addition, the effects of either bulk-sized or nano-sized ZnO 
particles were compared in the mouse atopic dermatitis (AD) skin model. The results 
clearly demonstrated that ZnO particles were able to suppress local inflammation, 
however, there was also an induction of systemic antibody (Ab) levels. These 
outcomes were clearly higher if the mice skin had been treated with nano-ZnO 
shown also to penetrate into the deeper layers on mouse allergic skin. These results 
highlight that particle size is an important parameter in determining the toxicological 
outcome and suggest that the effect may be attributable to the higher active surface 
area on smaller particles.
If these results are considered in the light of current risk assessment protocols, 
they emphasize the importance of careful physico-chemical characterisation of ENM 
if one wishes to compare the results with those in the literature. Furthermore, 
mechanistic studies revealing the pathways activated in the toxic outcomes in 
vitro should be further validated in vivo in order to utilise this information in the 
future in the more rapid screening of fibre toxicity. Taken together, these results 
highlight the weaknesses and strengths in the scientific data in the traditional risk 
assessment approach and these have to be taken into account in the planning of 
the future studies.
6tIIvIstelmä
Immuunijärjestelmä suojelee ihmistä erilaisilta patogeeneilta ja vierasmateriaaleilta. 
Yleisimmin patogeenit kulkeutuvat kehoon hengitysteitse, ruuansulatuskanavan 
tai ihon kautta. Ensimmäinen kehon suojamekanismi on epiteelisolukerros, joka 
antaa fyysisen suojan kehon pinnalle.  Fyysiseen suojaan liittyy myös suojaava 
limaneritys soluista sekä solut, joilla on erikoistehtävä, kuten värekarvalliset solut 
keuhkoissa. Myös biokemialliset suojausmenetelmät kuten entsyymit toimivat osana 
kehon puolustusmekanismeja. Nämä suojausmekanismit ovat osa synnynnäistä 
immuniteettia, nopeaa ja epäspesifistä tulehdusreaktiota. Synnynnäisessä 
immuunivasteessa toimii myös erityisiä soluja, jotka siivoavat kehon onkaloita 
vierasmateriaaleista ja erittävät viestinvälitysmolekyylejä, jotka sitten aktivoivat 
muita tulehdusvasteen soluja. Makrofagit ja dendriittiset solut ovat paitsi 
syöjäsoluja, myös kykeneväisiä esittelemään antigeeneja hankintun immuniteetin 
toimijasoluille, ja siten aktivoimaan spesifisen tulehdusvasteen taudinaiheuttajia 
vastaan T ja B – soluaktivaation avulla. Kun tulehdusvaste toimii normaalisti, sitä 
ei käytännössä huomaa, mutta jos tulehdusvaste on epätasapainossa, voi aiheutua 
erilaisia ongelmia, kuten allergioita. 
Teollisesti tuotetut nanomateriaalit ovat laajassa käytössä, sillä niiden 
ainutlaatuiset ja houkuttelevat ominaisuudet parantavat tuotteiden kilpailukykyä 
ja mahdollistavat innovaatioita ja niihin liittyviä kaupallisitamismahdollisuuksia. 
Onkin arvioitu, että nanoteknologiaa hyödyntävien innovaatioiden markkinakoko 
on yli 2 biljoonaa euroa vuonna 2015. Nanomateriaalien vaarallisuuden 
tutkimus laahaa kuitenkin jäljessä, sillä tuhansia erilaisia nanomateriaaleja 
käytetään jo tuotannossa ilman tarkkaa tietoa niiden terveydelle haitallisista 
ominaisuuksista. Nanomateriaalien riskinarviointi vaatii tietoa paitsi niiden 
haitallisista ominaisuuksista, mutta myös mahdollisesta altistumisesta, ja siksi eri 
tutkimusalueiden yhteistyö on tarpeellista. Lisäksi iso määrä eri tavalla muunneltuja 
nanomateriaaleja asettaa haasteen kehittää uusia, nopeampia ja halvempia 
riskinarviointitapoja ihmisten terveyden turvaamiseksi. 
Tässä väitöskirjassa vertailtiin erilaisia nanomateriaaleja ja tutkittiin 
materiaalien koon, muodon ja pintakäsittelyn vaikutuksia niiden terveydelle 
haitallisiin ominaisuuksiin. Tulokset osoittavat, että kemiallisesti erilaisilla 
nanomateriaaleilla on erilaiset terveydelle haitalliset ominaisuudet. Lisäksi tulokset 
tuovat lisävalaistusta nanomateriaalien, erityisesti nanoputkien, haittavaikutusten 
mekanismeihin. Solumalleilla tehdyt tutkimukset osoittavat, että erilaiset 
nanomateriaalit aiheuttavat erilaisen vasteen antigeenia esittelevissä soluissa ja että 
metallioksidien pintakäsittely ja hiilinanoputkien muoto vaikuttavat voimakkaasti 
7niiden haitallisiin ominaisuuksiin. Mekanistinen solututkimus hiilinanoputkilla 
osoittaa, että pitkät ja jäykät hiilinanoputket muistuttivat vaaraominaisuuksiltaan 
asbestikuituja, sillä molemmat aktivoivat tulehdusvastetta säätelevää NLRP3 
inflammasomia. Makrofageista eritettyjä proteiineja tutkiva proteomiikkatutkimus 
erilaisilla hiilinanoputkilla ja asbestikuiduilla osoittaa että erilaiset hiilinanoputket 
aiheuttavat erilaisen vasteen makrofageissa. Näin ollen kaikki hiilinanoputket 
eivät välttämättä ole yhtä vaarallisia. Lisäksi tutkimuksessa vertailtiin mikro- 
ja nanokokoisten ZnO hiukkasten vaikutusta hiiren atooppisen ihottuman 
tautimallissa. Tulokset osoittavat selvästi, että ZnO hiukkaset alentavat paikallista 
tulehdusta ihossa, mutta aiheuttavat kuitenkin nousun veren vasta-ainetasoissa. 
Kun hiiren iho käsiteltiin nanokokoisella ZnO hiukkasilla, vaikutukset olivat selvästi 
suuremmat kuin mikrokokoisilla ZnO hiukkasilla, ja nanokokoiset ZnO hiukkaset 
myös tunkeutuivat syvemmälle ihoon allergisessa ihomallissa. Nämä tulokset 
osoittavat, että hiukkaskoko on tärkeä aineen vaaraominaisuuksille, todennäköisesti 
pienikokoisemman hiukkasen korkeamman aktiivisen pinta-alan takia. 
Kun tuloksia analysoitiin nykyisillä riskinarviointitavoilla, oli selvää, että 
huolellinen aineen fysiko-kemiallisten ominaisuuksien kuvaaminen on välttämätöntä 
tulosten vertailtavuuden kannalta. Mekanistinen tutkimus osoitti solunsisäisten 
reittien aktivoitumisen solumalleissa, ja näiden toksikologisten mekanismien 
vahvistaminen oikeiksi eläinmalleilla olisi välttämätöntä, jotta tuloksia voitaisiin 
hyödyntää tulevaisuudessa kuitujen vaarallisuuden nopeassa seulonnassa. 
Väitöskirjan osatöiden tarkastelu kemikaaliriskinarvioinnin näkökulmasta 
paljastaa tieteellisesti tuotetun tiedon puutteet ja vahvuudet perinteisessä 
riskinarviointitavassa. Tulokset auttavat myös ottamaan huomioon tekijöitä, jotka 
ovat tärkeitä suunniteltaessa ja toteutettaessa uusia toksisuustutkimuksia.
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abbrevIatIons
Ab  Antibody
AD  Atopic dermatitis 
ADI  Accepted daily intake
APC  Antigen presenting cells 
ATP  Adenosine triphosphate
Bcl  B-cell lymphoma
bmDC Bone-marrow derived dendritic cells
bZnO  bulk-sized ZnO
CB  Carbon black
CNM Carbon nanomaterials
CNT  Carbon nanotubes
DAMP Danger-associated molecular pattern 
DC Dendritic cells 
DCNT  Double-walled carbon nanotubes 
DNA  Deoxyribonucleic acid
EChA European Chemicals Agency
ENM  Engineered nanomaterials
FACS  Flow cytometry 
FBS  Fetal bovine serum
GHS  Globally Harmonized System of Classification and Labelling of Chemicals
gI  gastro-intestinal
gLP  good laboratory practice
gM-CSF  granulocyte macrophage colony stimulating factor
HARN  High aspect ratio nanomaterials
IFN  Interferon
Ig Immunoglobulin 
IL Interleukin 
IPCS International Programme of Chemical Safety
LC  Langerhan’s cells
LDH  Lactase dehydrogenase
LPS  Lipopolysaccharide
MoA  Mode of action
MOx  Metal oxide 
mRNA Messenger ribonucleic acid
MCNT  Multi-walled carbon nanotubes
MHC Major histocompability complex
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Abbreviations
MW  Multi-walled
NLR NOD-like receptor
NM Nanomaterials
NOAEL  No observed adverse effect level
NP  Nanoparticles 
nZnO  Nano-sized ZnO
OECD Organisation for Economic Co-operation and Development
OVA  Ovalbumin
PAgE  Polyacrylamide gel electrophoresis
PAMP  Pathogen-associated molecular patterns 
PBS  Phosphate buffered saline
PRR Pattern-recognition receptor 
QSAR  Quantitative structure-activity relationship 
RA  Risk assessment 
REACH Registration, Evaluation, Authorisation and Restriction of Chemicals
RNA Ribonucleic acid
ROS  Reactive oxygen species
RT-PCR  Reverse transcription polymerase chain reaction
SCNT  Single-walled carbon nanotubes
SDS  Safety data sheet 
SEB Staphylococcal enterotoxin B
siRNA  Small interfering ribonucleic acid
SVHC Substances of very high concern
Syk  Spleen tyrosine kinase
SW  Single-walled
S. aureus  Staphylococcus aureus
Tc   T cytotoxic
TCR  T cell receptor 
TDI Tolerable daily intake 
TEM Transmission electron microscope
TFH  T follicular helper cell
Tg  Test guidelines
Th  T helper
TLR  Toll-like receptor
TNF  Tumor necrosis factor 
T reg  T regulator
UV Ultraviolet
WHO  World Health Organisation
WOE  Weight of evidence
WB Western blot
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1 IntroductIon
The immune system protects human beings from foreign agents such as viruses, 
bacteria and particular matter (Murphy, 2011). Skin, respiratory system and 
gastrointestinal tract are the main routes for foreign agents to enter the human body, 
and they are protected by a sophisticated network of functions. The mechanistical 
barrier, the epithelium, covers body surfaces and prevents entrance of foreign agents 
into the body. In addition to this property, chemical protection such as mucus 
which contains e.g. enzymes and proteases in the lungs strengthen the protective 
barrier in the borders of the body. The first line defence cells of immunity, such as 
macrophages and dendritic cells functionally protect the body by phagocytosing 
foreign agents entering the body. These cells act as general scavengers in the borders 
of the body and aim to destroy and inactivate pathogens, or to activate other types 
of immune cells by secreting inflammatory mediators and/or antigen presentation. 
If the immune reaction is successful, the foreign agent will be destroyed but if this 
fails and immune reaction becomes chronic, then health problems may ensue. 
Chronic inflammation may cause damage to the surrounding tissue and induce 
severe pathogenic outcomes, even the development of cancer.
Innate immune system cells operate in the first step of the immune reaction 
(Stampfli and Anderson, 2009). The response is non-specific and rapid and does 
not create immunological memory. Innate immunity cells may activate adaptive 
immune response which in turn is specific, slower but does leave an immunological 
memory ((Bonilla and Oettgen, 2010; Stampfli and Anderson, 2009). Cytokines 
and chemokines are secreted by different cell types to strengthen, weaken or to 
polarise immune response (Joshi and Knecht, 2013). Since it is the professional 
phagocytes that operate in the innate immunity reactions, T and B cells are mostly 
responsible of adaptive immune responses. In the successful immune response, 
there is a complex network of cells all operating simultaneously to ensure that 
invading foreign agents are neutralized.
Engineered nanomaterials (ENM) are widely used in many industries, and 
it has been estimated that nanotechnology-based manufacturing companies will 
employ millions of workers in the following decade (Castranova, 2011; Medina et 
al., 2007). ENM are defined as particles or materials with at least one dimension 
between 1–100 nm (EU, 2009). Multiple different types of nanomaterials exist, 
such as carbon-based nanomaterials (NM), metal and metal oxide nanoparticles 
(NP) (Elsaesser and Howard, 2012; Shi et al., 2013). Carbon-based nanomaterials, 
such as carbon black (CB) particles and carbon nanotubes (CNT), may be used in 
electronics, sports equipment, car tires or inks, to mention a few sectors. Metal 
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1 Introduction 
oxide (MOx) NP, such as titanium dioxide (TiO2), silicon dioxide (SiO2) and zinc 
oxide (ZnO), are used for example in the cosmetics, pharmaceuticals, inks, food 
products or plastics. It is alarming that despite the wide use of ENM their health 
effects have remained poorly characterised (Castranova, 2011).
The special characteristics of ENM i.e their microscopic size (< 100 nm) influence 
on their toxicity (Castranova, 2011; Elsaesser and Howard, 2012). Small particle size 
means a large surface area and increased reactivity, because reactivity of a particle 
is associated with its surface area and other surface properties. Particle surface 
functionalization, reactive oxygen species (ROS) generation and ion dissolution have 
been assumed to influence the ENM toxicity, as well as physical characteristics of 
ENM such as their shape.  In addition, the tendency of ENM to form weakly bound 
complexes with similar active surface area as single particles (agglomerate) or the 
tendency to form strongly bound complexes with smaller active surface area than 
in agglomerates (aggregate) has a high influence on the toxic properties of ENM 
(Nel et al. 2006). Toxiciological studies have shown that some types of CNT can 
induce local inflammation, fibrosis and even cancer in vivo (Poland et al., 2008; 
Takagi et al., 2008). On the other hand, some types of CNT do not seem to be 
hazardous to health at least in vitro or in vivo experiments. The identification of 
toxic characteristics and the mechanism of ENM toxicity are essential for grouping 
of ENM into non-hazardous and hazardous materials (Nel et al., 2013).
The traditional risk assessment (RA) requires information on a chemical’s 
hazardous characteristics and data from human exposure in order to characterise 
and manage risks (WHO/IPCS 2010). Hazard identification and characterization are 
based on standardized testing protocols performed under good laboratory practice 
(gLP) in testing laboratories. gLP is referred as a management system aiming to 
ensure quality, i.e. reliability, reproducibility and consistency, of the studies (OECD, 
1998). The non-clinical safety-test pattern is expensive and time consuming as the 
RA process for one chemical may take years. On the other hand, based on the RA 
efficient risk management measures can be set and risk for health hazards can be 
minimized. It has been emphasized that in the case of nanomaterials, the current 
approach of RA is not applicable to protect people, especially in the industrial 
processes (Hristozov et al., 2012). In addition, immunotoxicology testing which is 
commonly utilized as a first step of nanotoxicity assessment is not recognised as 
a part of non-clinical testing of chemicals. As thousands of differentially modified 
ENM are used in the manufacturing of products, a more efficient RA method should 
be developed and the data published in science should be analysed as a part of risk 
evaluation (Nel, 2013). In addition, the suitability of standardized testing protocols 
needs to  be clarified as there is the possibility for false negative or positive results 
if ENM interfere with assays (Nel et al., 2013).
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The aim of this thesis was to investigate the effects and mechanisms of immune 
response caused by different ENM. Professional phagocytes, macrophages and 
dendritic cells, were used as cell models of the innate immunity cells able to activate 
adaptive immune responses. The activation of production and secretion of cytokines 
and chemokines was studied in order to compare different ENM, and intracellular 
cascades regulating pro-inflammatory, e.g. IL-1 family, cytokine secretion were 
investigated after CNT and asbestos exposure. Proteomics tools were used to 
characterise the full picture of secreted proteins from macrophages and different 
CNT were compared with asbestos fibres. Furthermore, the effects of nano- and 
fine-sized ZnO particles were investigated in a mouse atopic dermatitis disease 
model. Finally, the usefulness of scientific data in the hazard identification and 
characterisation in the RA process was discussed.
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2 Immunity and cell death
2 ImmunIty and cell death
The human body is protected from pathogens and invasion of foreign matter by 
the immune system (Murphy, 2011). The immune system is a complex network 
divided into two functional parts: innate and adaptive immune responses which both 
consist of a wide range of specialised cells and signalling molecules. A substance 
inducing an immune reaction is called an antigen, and the proteins produced by 
specialised cells against antigens are antibodies. The immune system has to create an 
effective immune response to protect the body from invading pathogens or foreign 
materials (Murphy, 2011). Cell death is also tightly associated with inflammation. 
Necrosis induces cell swelling and the release of cell contents leads to the promotion 
of inflammation in the surrounding tissue whereas activation of inflammation-
associated cell signalling cascades triggers different forms of cell death, e.g. apoptosis 
or pyroptosis (galluzzi et al., 2012).
2.1 ActivAtion of the innAte immunity
2.1.1 cells of the innAte immunity
Innate immunity is a non-specific system intended to destroy different pathogens 
or foreign matter invading the body (Murphy, 2011).  It does not create an 
immunological memory but is a rapid and effective system for eliminating invading 
agents, as it is the first line of defence capable of activating adaptive immunity. 
Physical and biochemical barriers such as skin and surface of respiratory and gastro-
intestinal (gI) tract as well as different enzymes in the body are important parts 
of the innate immunity, but the main participants in the response are the immune 
cells such as neutrophils, macrophages and dendritic cells (DC). These cells are 
capable of phagocytosis, and they are the main part of innate immunity. They are 
professional phagocytes acting in the innate immunity and besides their scavenging 
role of body cavities, these phagocytes are also capable of producing large amounts 
of toxic chemicals, degradative enzymes and pro-inflammatory mediators to protect 
body against pathogens. Neutrophils are present throughout the body and are 
usually the first type of cells attracted to the site of inflammation. They phagocytose 
and destroy pathogens in their intracellular vesicles with degradative enzymes. 
They are incapable of antigen presentation but effectively activate bacteriocidal 
mechanisms (Murphy, 2011). Macrophages and DC are a link between innate and 
adaptive immunity as they are capable of priming and activating other immune cells 
by antigen presentation (Barton, 2008; Stampfli and Anderson, 2009). Therefore 
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they are called professional antigen presenting cells (APC) and these cells are the 
most important activators of adaptive immune response. A simplified view of APC 
on the surface of body cavities is represented in the Figure 2.1.
figure 2.1. Antigen presenting cells located and functioning in the epithelial lining. 1. Macrophages in the 
body cavity; 2. Immature DC recruited from bloodstream; 3. Mature DC migrate to the local lymph nodes.
Monocytes circulate in blood and migrate into the tissues where they mature into 
macrophages. Macrophages are long living phagocytic cells resident in almost all 
tissues and body cavities, and they have an important role in both innate and adaptive 
immunity responses (gardner, 1984). The most important functions of macrophages 
are to phagocytose invading micro-organisms and particles as well as dead cells 
and debris as scavenger cells. In addition, they are also able to orchestrate the 
immune response by secreting signalling molecules (Murphy, 2011). As an example, 
the macrophages present in the lungs are called alveolar macrophages. They can 
recognise and kill pathogens in the early course of an infection to prevent them 
entering to the circulation. The production of pro-inflammatory mediators, reactive 
oxygen species (ROS) and proteolytic enzymes strives to eliminate pathogens (Joshi 
and Knecht, 2013; Stampfli and Anderson, 2009). 
Dendritic cells (DC) are present throughout the body, e.g.  in lungs, skin, liver 
and on the surfaces of body cavities. In addition to phagocytosis, they act to prime 
adaptive immune responses, to induce self-tolerance and to eliminate viral infections 
(Banchereau and Steinman, 1998). There are different types of DC in the different 
areas of body surfaces such as in the epidermis and in the gut mucosa (Langerhan’s 
cells; LC) and lungs (alveolar DC) (Banchereau and Steinman, 1998; Novak and 
Bieber, 2008; Shaw et al., 2012) where they are very responsive to the invading 
pathogens and foreign matter as well as to the allergens in chemical agents  (Kang 
and Compans, 2009; Shaw et al., 2012). DC engulf pathogens in tissues, and this 
leads to processing of pathogen antigens which are then presented onto the DC 
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surface. This process is called maturation, and during this phase, DCs migrate to the 
local lymph nodes where the T cells come into the contact with peripheral antigens 
presented by DC. In addition to engulfment of pathogens, the signals leading to 
DC maturation may be microbial patterns, danger signals or pro-inflammatory 
cytokines (Sousa, 2006). Maturated DCs are incapable of phagocytosing but are 
highly efficient in antigen presentation as well as in presenting co-stimulatory and 
adhesion molecules on their surface (Vermaelen and Pauwels, 2005). This process 
is an essential stage in evokinga powerful antigen-specific activation of T cells and 
B cells as well as in the regulation of their functions and responses, leading to 
efficient adaptive immune response (Banchereau and Steinman, 1998; Kang and 
Compans, 2009). 
2.1.2 nlRP3 inflAmmAsome comPlex
Macrophages and dendritic cells as well as other types of immune cells recognise 
evolutionarily microbial motifs throughx their pattern-recognition receptors (PPRs) 
such as Toll-like receptors (TLR) recognising pathogen-associated molecular 
patterns (PAMPs) and NOD-like receptors (NLR) recognising PAMPs and danger-
associated molecular patterns (DAMPs) (Schroder and Tschopp, 2010). Some PPRs 
are assembled into high molecular weight platforms, inflammasomes, controlling 
the maturation and secretion of interleukin (IL) -1 –family cytokines, such as IL-1β 
and IL-18 (Martinon et al., 2002). IL-1β is an important pro-inflammatory cytokine, 
which activation is tightly controlled by expression, maturation and secretion 
(Dinarello, 2010). Two signals are required for the secretion of active IL-1β: at 
first, a pro-inflammatory signal activates the expression of inactive pro-IL-1β in the 
cell cytoplasm. Secondly, another signal is required for assembly of inflammasome 
complex to activate caspase-1 enzyme cleaving pro-IL-1β into its active form which 
is then secreted (Schroder and Tschopp, 2010).
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figure 2.2. Large intracellular NLRP3 inflammasome complex consists NLRP3 scaffolds, ACS (PYD) adaptor 
molecule and pro-caspase-1 (pro-CASP-1) protein. Pro-CASP-1 is a complex of cardinal-1 (CARD) and 
caspase-1 (CASP-1) proteins. When the inflammasome is activated, active CASP-1 is released to cleave the 
inactive pro-IL-1β protein to active IL-1β protein to be secreted out from the cell. The figure represents one 
part of the large NLRP-3 inflammasome complex with still unknown number of units forming a full complex.
NLRP3 inflammasome consists NLRP3 scaffold, the ASC adaptor molecule and 
pro-caspase-1 protein. As NLRP3 inflammasome is activated, pro-caspase-1 is spliced 
into the active caspase-1 protein then able to cleave pro-IL-1β protein into its mature 
form (Figure 2.2). NLRP3 inflammasome is activated by multiple signals, such as 
whole pathogens, some PAMPs and DAMPs as well as environmental irritants such 
as asbestos fibres (Cassel et al., 2008) and silica particles (Hornung et al., 2008). 
Multiple mechanisms have been shown to activate the NLPR3 inflammasome such 
as K+ efflux via the P2X7 ATP gated ion channel, lysosomal damage and release of 
lysosomal contents into the cytoplasm especially if caused by particulate materials, 
generation of reactive oxygen species (ROS), activation of specific tyrosine kinases 
(Src and spleen tyrosine kinase Syk), and autophagy (Cassel et al., 2008; gross et 
al., 2009; Hornung et al., 2008; Saitoh et al., 2008). However, it is still not known 
whether the distinct NLRP3 inflammasome activation cascades are inter-regulated 
or required independently for the inflammasome assembly. 
2.2 ActivAtion of the AdAPtive immunity
2.2.1 cells of the AdAPtive immunity
Tissues, cells and molecules, which act together to provide specific and therefore 
effective defence system, form the adaptive immunity. The main characteristics of 
adaptive immunity are specificity, memory and discrimination between self and non-
self. The main effector cells of adaptive immunity are lymphocytes, T and B cells. They 
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are present in the secondary lymphoid organs, lymph nodes and spleen and their task 
is to eliminate evading pathogens. T and B cells can be activated by the circulating 
pathogens themselves through antigen binding on the receptors on the surface of T 
and B cells. In addition, antigen presenting cells activate and functionalise T and B cells 
via T and B cell receptors  (Bonilla and Oettgen, 2010). These very specific receptors 
recognise a particular antigen being presented by APC and focus the immune response 
on it. Immunological memory is also based on the large amount of rearranged receptors 
on the lymphocyte surface. In order to eliminate invading pathogens successfully, 
several levels of interactions between innate and adaptive immunity are required. Even 
although the adaptive immune reactions are more specific towards specific antigens, 
innate immunity still determines the nature of the adaptive T and B cell response 
(Kang and Compans, 2009).
T cells mature in the thymus and these are the major effector cells in cell-mediated 
immunity as T cells are activated by APC to create an adaptive immune response. 
T cells are classified as T cytotoxic (Tc) cells, T regulator (T reg) cells and T helper 
(Th) cells according to their distinctive cell surface markers. Tc cells express CD8+ 
surface marker, and recognise antigens bound onto the major histocompability 
complex I (MHCI) molecule whereas T reg and Th cells express CD4+ on their 
surface and recognise antigens bound to MHCII molecules. For example cytotoxic 
T cells destroy virus-infected cells by secreting effector molecules and are activated 
by APC and, in some cases, by Th cells. T reg cells suppress immune response by 
secreting TGF-β and IL-10 or direct cell-cell contact with for example Tc cells. On 
the other hand, Th cells activate macrophages, B cells and neutrophils to strengthen 
the adaptive immune response (Auriemma et al., 2013; Tangye et al., 2012). Th 
cells are divided into different subclasses based on the cytokines produced during 
the active phase. These subtypes are presented in Table 2.1. The differentiation of 
T cells into different lineages of response type is a complex process depending on 
multiple factors, such as the dose and type of antigen. Furthermore, T memory cells 
are generated during the first contact with antigen and these are responsible for 
creating the immunological memory capable of producing rapid immune response 
when challenged with the same antibody again. For example, macrophages and B 
cells are able to activate long-living T memory cells to destroy invading pathogen.
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table 2.1. Different T helper cell subsets, cytokines produced and their targets.  
Ab = antibody, TFH = T follicular helper cell.
T helper cell (Th) 
type
Typical cytokine production profile Targets
Th1 IFN-y, TNF-α Intracellular pathogens
Th2 IL-4, IL-5, IL-13, IL-31 Extracellular pathogens
Ab production by B cells
Th9 IL-9, IL-10 Recruitment of mast cells
Th17 IL6, IL-8, IL-17, IL-21, IL-22, Innate immunity regulation
Neutrophil recruitment
Th22 IL-22, IL-31 Unknown
TFH IL-21 B cell activation
B cells mature in the bone marrow and act in the humoral immunity by producing 
antibodies that have a role in pathogen elimination when they bind to the pathogens. 
This leads to their neutralisation by the complement system or their removal by 
phagocytic cells such as macrophages. The sophisticated communication network 
between T cells or DC with B cells leads to B cell differentiation into antibody 
producing plasma cells or memory B cells. These cells provide fast and effective 
removal of a pathogen after the subsequent appearance of the same pathogen in the 
body (Bonilla and Oettgen, 2010). Plasma cells produce antibodies (Ab) of different 
isotypes dependent on the antigen: IgA, IgD, IgE, Igg and IgM are produced in 
order to eliminate the pathogen. Different isotypes have different functions in the 
adaptive immune response. Igg is the most potent isotype secreted in humans 
opsonising pathogens to be ingested by phagocytes whereas IgE has an important 
function in the pathomechanisms underpinning allergy (Bonilla and Oettgen, 2010; 
Tangye et al., 2012).
2.2.2 AlleRgic ResPonses
Allergic response is a hypersensitivity immune reaction targetted at a substance 
that would not induce immune effects in a non-sensitized individual (Barnes, 2011). 
Allergic diseases are divided into types I-IV characterised by their immunoglobulin 
secretion. Type I allergy is mainly driven by immunoglobulin E (IgE) -dependent 
mechanisms and several inflammatory cells are involved in the allergic inflammation. 
Dendritic cells, lymphocytes, mast cells, basophils, eosinophils and neutrophils 
secrete inflammatory mediators to modify the functions of epithelial cells, fibroblasts 
or vascular cells, etc. The pattern of secreted inflammatory mediators varies 
extensively, and it may lead to immediate, delayed or chronic allergy. Other factors, 
such as the genetic background of individual or environmental factors, can all affect 
the outcome of an allergic inflammation therefore inducing chronic responses and 
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creating a complex group of allergic diseases such as allergies, atopic dermatitis and 
rhinitis. These diseases share some common features but have major differences 
in clinical outcomes. Mast cells initiate allergic immune responses through an IgE-
dependent mechanism, which in turn attracts DC to the site of allergic inflammation. 
DC recruit T cells to the site of inflammation to secrete cytokines important in the 
immune response. T reg cells are also present at the site of allergic inflammation 
where they strive to suppress allergic inflammation (Barnes, 2011; Johansson, 2011). 
Cytokines then activate eosinophils and B cells to release IgE further activating 
mast cells. In addition, the histamine, leukotrienes, prostaglandins and cytokines 
secreted by mast cells worsen allergic reactios, independently of the type of allergic 
disease (Johansson, 2011). 
One example of an allergic disease is atopic dermatitis (AD), which is a chronic 
and relapsing inflammatory skin disease characterised by the presence on lesions 
and pruritus as well as eosinophil infiltration in the skin and high levels of IgE in 
plasma. The prevalence of AD is 15–30% in children and 2–10% in adults, and it 
has been a growing problem in the industrial countries over last decades suggesting 
that there may be an even higher disease prevalence in the future (Bieber, 2010; 
Johansson and Bieber, 2002). The allergic reaction in the skin causes itching, 
which leads to scratching mechanically damaging epithelial barrier. This worsens 
the inflammation locally in the skin.  Infective bacteria, e.g. Staphylococcus aureus 
(S. aureus), are common in the skin but they do not cause any pathogenic effects in 
the undamaged skin (Barnes, 2011). However, in the damaged and diseased skin, 
these bacteria are able to form colonies due to the decreased production of anti-
microbial peptides.  S. aureus colonisation leads to the release of its enterotoxins 
such as the superantigen Staphylococcal enterotoxin B (SEB). This activates B and T 
cell proliferation and extensive IgE production (Barnes, 2010) subsequently causing 
to IgE sensitisation. It is known that the alteration of the functions of T reg cells is 
an important step in the pathogenesis of AD (Bieber, 2010).
2.3 inflAmmAtoRy mediAtoRs
Immune cells signal to each other by secreting small proteins, peptides or glycoproteins 
called cytokines or chemokines or by expressing co-stimulatory molecules on their 
surface. Cells may also secrete other kinds of mediators, such as lipids, purines or 
reactive oxygen species (ROS) to activate the inflammatory cascade (Barnes, 2011). 
In particular epithelial cells, macrophages and T cells secrete mainly cytokines 
whereas antigen-presenting cells (APC), such as dendritic cells, may activate T 
cells by expressing co-stimulatory molecules on their cell surface. Multiple different 
cytokines are secreted after the appearance of the activation stimulus. In general, 
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inflammatory responses are induced by cytokines binding to specific receptors, 
which then activate signalling cascade resulting in a cytokine-specific response. 
This drives immune response by cell recruitment and cell differentiation into the 
specific subtypes (Auriemma et al., 2013). 
Cytokines activating different innate immune responses are most often IL-1 
–family cytokines, such as IL-1β and IL-18, or IL-6, tumor necrosis factor (TNF) 
-α or interferon (IFN) -γ. IL-1 –family cytokines, IL-6 and TNF-α induce pro-
inflammatory reactions against different pathogens such as bacteria, whereas 
IFN-γ exerts significant antiviral activity. IL-8 is also associated with innate 
immune responses as it attracts neutrophils to the infection site. These cytokines 
are produced not only by phagocytes but also by numerous other cell types such as 
endothelial cells and keratinocytes. TGF-β and IL-10 are the cytokines responsible 
for anti-inflammatory actions. TGF-β activates T reg cells which then secrete IL-10 
suppressing many inflammatory reactions such as the IgE production by mast cells. 
In addition, the chemokines secreted by immune cells induce chemotaxis of nearby 
responsive cells such as monocytes and neutrophils to the site of inflammation. All 
secreted inflammation mediators together form a sophisticated balanced immune 
response which should successfully eliminate any  pathogen  (Borish and Steinke, 
2003).  
Activated APC express co-stimulatory molecules (CD40, CD80, CD86) on their 
surface mostly through pattern recognition receptor (PRR) -mediated recognition 
of a pathogen. The presentation of co-stimulatory molecules to naïve T CD4+ cells 
can promote their differentiation into Th1 cells or Th2 cells (Kang and Compans, 
2009). In order to activate T cells efficiently, APC must express T cell co-stimulatory 
molecules to be bound to T cells. The non-specific interaction between these co-
receptors and their ligands strengthens the specific interactions between T cell 
receptor (TCR) and antigenic peptides associated with major histocompability 
complex (MHC) class I or MHC class II and leads to activation of T cells in the 
adaptive immune response (Neefjes et al., 2011).
2.4 cell deAth 
Cell death is one of most primitive host defences against an invading pathogen 
and it is also essential to maintain cellular homeostasis. Programmed cell death 
achieves the removal of unnecessary cells during embryogenesis, virus infected cells 
are recognised and killed by specialised cells to avoid the spread of infection and 
tumorous cells are intended to be recognised and destroyed. A failure in the cell 
death processes can lead e.g. to tumour development. Multiple proteins, cascades 
and recognition mechanisms tightly regulate cell death processes since these are 
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essential for the normal functions of the organism. Different cell death types can be 
distinguished based on the morphological criteria in conjuction with the biochemical 
and functional characteristics. The different forms of cell death have their unique 
characteristics but also share some common features. In the following sections, some 
common forms of cell death, necrosis, apoptosis and pyroptosis, will be described 
briefly (Galluzzi et al., 2012). The successful cell death process requires crosstalk 
between different cell death subroutines with a high level of complexity, and leads 
to the phagocytosis of dead cells by professional and non-professional phagocytes 
(Vandenabeele et al., 2010).
2.4.1 necRosis
Necrosis is a pathological process, where a group of cells or even tissues die as a 
response to some overwhelming trauma (Leist and Jaattela, 2001). In the necrotic 
process, the cell and its components such as mitochondria swell due to water influx 
and this leads to the disruption of ion homeostasis. Eventually cell membrane 
integrity is lost, the cell swells more and breaks down releasing cell components into 
the surrounding tissue. This typically induces profound inflammation (Vanderabeele 
et al. 2010). For example, adenosine triphosphate (ATP) released from necrotic cells 
activates NLRP3 inflammasome in the surrounding cells leading to release of IL-1 
–family cytokines. Necrosis is considered to be an accidental form of cell death, but 
recent studies have indicated that it may be regulated by a set of signal transduction 
pathways and catabolic mechanisms (galluzzi et al. 2014). This regulated cell death 
process is commonly called necroptosis, however, there are some aberrations in 
the nomenclature (galluzzi et al., 2012). The regulated necrosis has a role in some 
physiological and pathological settings such as alkylating deoxyribonucleic acid 
(DNA) damage, and it is characterised with regard to specific signalling molecules.
2.4.2 APoPtosis
Apoptosis is a highly controlled process leading to cell death of single cells. It is 
energy-dependent, and leads to deletion of unwanted cells in the physiological 
processes and in the pathological conditions it may be an attempt to maintain 
homeostasis (Kerr et al., 1972). The apoptotic process depends on the anti-apoptotic 
and pro-apoptotic signals. Inhibition of apoptosis is intended to allow cells time to 
repair the cellular damage, and multiple stimuli such as growth factors, cell matrix, 
and some viral proteins have anti-apoptotic functions. Apoptosis may be induced 
by intracellular stress conditions such as DNA damage, oxidative stress, cytosolic 
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calcium (Ca2+) overload, or pathological stimuli such as ionising radiation (galluzzi 
et al., 2012). In mammalian cells, apoptosis may be an extrinsic or intrinsic process 
i.e. the extrinsic process is dependent on so-called death receptors expressed in 
plasma membrane and caspase signalling whereas the intrinsic process is dependent 
on mitochondria-controlled signalling and may be either a caspase-dependent or 
a caspase-independent process (Andon and Fadeel, 2012).
Morphological criteria associated with apoptosis have been used to recognise 
the process by observation under the light microscope (galluzzi et al., 2012). The 
apoptotic cell becomes round-shaped, the cellular volume is reduced (pyknosis), 
chromatin and nucleus are fragmented (karyorrhexis) and pseudopods are retracted 
but cytoplasmic organelles including lysosomes remain intact. Cell membrane 
integrity is maintained and the cell first shrinks and then fragments to form apoptotic 
bodies which can be phagocytosed and eliminated  by phagocytosing cells (Kerr et 
al., 1972).  Multiple proteins, such as B-cell lymphoma (Bcl) -2 protein family, are 
involved in the regulation of apoptosis. These proteins have important roles in the 
control of intrinsic apoptosis by controlling the formation of the apoptosome. The 
apoptosome is a multi-protein complex consisting of cytochrome c, deoxyadenosine 
triphosphate (dATP), apoptotic protease-activating factor-1 (Apaf-1) and pro-
caspase-9 and it serves as a platform to activate caspases (Andon and Fadeel, 2012). 
Caspases are enzymes belonging to a family of cysteine-dependent proteases that 
cleave their substrates in the cytoplasm. They function as initiators or executors 
of apoptosis and are involved in the different processes of inflammation such as 
IL-1 -family cytokine maturation (Lamkanfi et al., 2009) as well in the process of 
pyroptosis described below (Bergsbaken et al., 2009).
2.4.3 PyRoPtosis
Pyroptotic cells share morphological features with both necrosis and apoptosis 
but pyroptosis is a biochemically distrint process (Bergsbaken et al., 2009). The 
biochemical feature of pyroptotic cell death is the activation of caspase-1 in the 
early phase of the cell death process, and this has been associated with the NLRP3 
inflammasome, also called the pyroptosome, activation. As described in chapter 
2.1.2, NLRP3 inflammasome regulates the activation and secretion of known 
pyrogenic cytokines, IL-1 –family cytokines. It is still unclear why caspase-1 
activation sometimes leads to cytokine secretion without cell death and sometimes 
triggers pyroptosis, more research into this process will need to be conducted in 
the future (galluzzi et al., 2012). Caspase-1 is not involved in apoptosis or necrosis 
and in this respect it differs from the apoptotic caspases. In turn, caspase-3 or 
caspase-8, are not involved in pyroptosis (Bergsbaken et al., 2009).
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Pyroptotic cells suffer from rapid plasma-membrane rupture by pore formation 
in the plasma membraneleading to water influx, cell swelling and a significant 
increase in cell size and, eventually, to osmotic lysis. The uncontrolled cell lysis 
leads to release of pro-inflammatory contents into the surrounding tissue causing 
extensive inflammation. All of the functions and targets of caspase-1 are still not 
known, and more research is currently being conducted in attemps to clarify the 
mechanism and features of pyroptosis (Bergsbaken et al., 2009). 
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3 nanomaterIals 
The European Union defined nanomaterials in  2011 as ‘a natural, incidental 
or manufactured material containing particles, in an unbound state or as an 
aggregate or agglomerate; where 50% or more of the particles exhibited, one or 
more external dimensions in the size range of 1–100 nm’ (EU, 2011). Figure 3.1 
demonstrates the size relation of nanomaterials to different sized objects such as 
lung alveoli and salt grain. Engineered nanomaterials (ENM) are widely utilised by 
different industries and nanotechnology has been claimed to provide possibilities to 
improve the competitiveness of the products and industrial sectors responding to 
societal challenges (Medina et al., 2007). In fact, EU has nominated nanotechnology 
as a key enabling technology of industry (EU, 2009). Many industrial branches 
use ENM to make their products user-friendlier or to improve their market 
competitiveness, for example in the electronics, cosmetics and sports industry 
sectors as well as in pharmaceuticals, diagnostic tools and medical imaging. It has 
been estimated that millions of workers worldwide operate in the nanofield before 
2020 (Castranova, 2011). Therefore, the most common way to become exposed 
to ENM is in occupational settings, either via inhalation or dermal exposure. The 
challenge is that there is not sufficient knowledge of risk of the hazard, toxicity or 
the environmental effects of ENM (Hristozov et al., 2014b; Nel, 2013). As human 
exposure to ENM is likely to increase, substantially in the future identification 
and quantifying of potential health hazards of ENM is essential for the human 
health risk assessment and for setting the appropriate risk management measures 
to protect people for the health effects induced by exposure to ENM (Hristozov et 
al., 2012; Kroll et al., 2009). 
figure 3.1. An illustration describing the size of different objects in comparison to engineered nanomaterials.
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3.1 geneRAl PRoPeRties
There are several groups of nanomaterials classified by their physical and chemical 
characteristics (Elsaesser and Howard, 2012). Metal nanoparticles (NP), metal oxide 
NP, carbon nanomaterials (CNM) and carriers or vehicles in the drug delivery are 
examples of different groups of ENM and are described as follows.  For example, 
gold (Au), silver (Ag) and copper (Cu) can be produced as nanosized particles. 
In the industrial use, metal oxide NP are excellent catalysts and have interesting 
optical properties depending on particle size and shape. For instance, nano-sized 
iron oxide (FeOx), titanium dioxide (TiO2), zinc oxide (ZnO) and copper oxide 
(CuO) represent metal oxide nanoparticles. These materials are used commonly in 
biomedical imaging and in cosmetics to improve properties of beauty products and 
to produce user-friendly sunscreens, and they can also be utilised in drug delivery 
(Medina et al., 2007; Nath and Banerjee, 2013; Shi et al., 2013). Another main class 
of nanomaterials are made out of carbon. Different types of CNM such as carbon 
black (CB), fullerenes, graphene, single-walled (SCNT), double-walled (DCNT) 
and multi-walled (MCNT) carbon nanotubes have high electrical conductivity and 
excellent strength. In an ideal carbon nanotube (CNT), a graphene sheet is rolled 
and welded into a seamless tube (Luo et al., 2013). MCNT has more graphene layers, 
and is thicker and more rigid  whereas one-layered graphene roll forms SCNT (De 
Volder et al., 2013). CNT are commonly used in many sectors of industry, such 
as electronics, catalytic processes and in sports equipment such as tennis rackets 
(Dumortier, 2013).
Several types of ENM have been used as carriers in the drug delivery, utilising 
liposome as a carrier structure. These lipid vesicles carry drugs to the target cells and 
release their contents (Lian and Ho, 2001). In addition to pharmaceutical products, 
liposomes are used in cosmetics, such as in shampoos and skin care products (Hoet 
et al., 2004).  Microemulsions are commonly used to enhance the solubility of 
insoluble materials and to aid the transport of pharmaceuticals in the body (Spernath 
and Aserin, 2006). Biodegradable polymers have been developed for use in drug 
delivery systems and implant materials. Ceramic NM are inorganic systems with 
porous characteristics and they have been claimed to serve as drug vehicles in 
cancer therapy but thet seem to be non-biodegradable and a major concern is the 
possible accumulation in the body causing unwanted effects (Medina et al., 2007; 
Yih and Al-Fandi, 2006). The ability of certain ENM to cross the body’s protective 
barriers may serve as a tool for therapeutics but also a source of unwanted effects, 
for example should an ENM cross the placental barrier (Pietroiusti et al., 2013).
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3.2 unique chARActeRistics
Nanomaterials may be potentially more toxic than fine-sized particles of the same 
materials because of their unique physicochemical properties such as shape, particle 
size distribution, surface characteristics like coating and charge, solubility and level 
of aggregation or agglomeration (Elsaesser and Howard, 2012). When size decreases, 
the specific surface area per mass unit increases and the NP becomes more reactive 
than its fine-sized particle counterpart (Castranova, 2011). For example, it has been 
demonstrated that solubility of ZnO particles increases when its size decreases (Reed 
et al., 2012). The coating of a NP may change its properties drastically, for example 
from being hydrophilic to hydrophobic, and modify their surface reactivity (Nel et 
al., 2006; Shi et al., 2013). Although these unique characteristics may be considered 
as an attractive property of ENM, they also may pose human health risks. Therefore 
a careful characterisation of material properties should be required for all studies 
performed with ENM to allow comparison of data and to provide information for 
risk assessment purposes (Shi et al., 2013). In addition, surface characteristics of 
ENM can affect on the formation of the protein corona on the material surface, 
which will be further discussed in 3.5. 
3.3 immune ResPonse And toxicity
generally, when foreign materials enter the body they are removed by the normal 
defence systems in the body such as ciliated cells and mucus secretion in the lungs 
or engulfed by the phagocytosing cells such as macrophages. This may lead to 
total cleavage of materials but scavenger cells may also secrete pro-inflammatory 
signalling molecules to activate other types of immune cells (gwinn and Vallyathan, 
2006). ENM may also evoke the production of reactive oxygen species (ROS) 
inducing oxidative stress capable of activating innate immune response (Hornung 
et al., 2008) or induce release of pro-inflammatory cytokines independently of ROS 
production (Lu and Liu, 2009). In addition, it has been postulated that NM may 
escape phagocytosis, cross cell membranes and redistribute to other sites of body 
and lead to systemic effects such as cardiovascular diseases or dissolute to reactive 
ions after entering the cell, for example in the acidic environment in lysosomes (Reed 
et al., 2012, Kettiger et al., 2013). However, the ability of ENM to cross membranes 
may be used in treatment of diseases e.g. in the targeted cancer therapy (Elsaesser 
and Howard, 2012). 
ENM may evoke different types of cell death, such as necrosis or apoptosis 
(Andon and Fadeel, 2012). Apoptosis may be induced by mitochondrial perturbation 
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and the release of pro-apoptotic factors. Frustrated apoptosis by macrophages in 
the case of high aspect ratio nanomaterials (HARN) may lead to release of pro-
inflammatory mediators and eventually to the development of fibrosis in the target 
organ (gou et al., 2010). Impurities such as residual transition metals, like iron 
(Fe) or nickel (Ni), from the CNT production process possibly potentiate CNT 
reactivity with macrophages and epithelial cells (Castranova et al., 2013; Luo et 
al., 2013). Other types of injuries are also possible after the exposure to ENMs 
including protein denaturation, membrane or DNA damage, the formation of foreign 
body granulomas and binding of the proteins to ENM surface leading to cellular 
malfunctions (Elsaesser and Howard, 2012; Luo et al., 2013; Nel et al., 2006). 
To summarise, there is an urgent need for more precise knowledge of mechanisms 
of ENM toxicity (Clift and gehr 2011). Mechanistical information can form a basis for 
developing qualified risk assessment methods for screening of nanomaterial toxicity. 
In vitro –assays are rapid, simple and cheap as compared to in vivo –studies but 
they do not reveal the entire scope of the possible toxicity. In addition, co-cultures 
of multiple cell types are a valid alternative for in vitro –screening of toxicity (Dekali 
et al., 2012). On the other hand, the possibility of ENM interference with assays 
has to be studied carefully to avoid relying on false positive or negative results in 
toxicity testing. One example of known interference occurs with Organisation for 
Economic Co-operation and Development (OECD) guideline 471, Bacterial reverse 
mutation assay, this test for genotoxicity (Ames test) and it should be excluded 
from the ENM genotoxicity test battery (Clift et al 2013). To conclude, one crucial 
part of the nanomaterial toxicity testing is to develop suitable testing assays and to 
ensure that the existing methods are suitable for evaluating ENM.
3.4 PotentiAl exPosuRe Routes
The most common exposure routes to ENMs are inhalation, dermal and gastro-
intestinal exposure. Inhalation exposure to ENMs occurs mostly due to occupational 
exposure during the production of nanomaterials or nanomaterial-based products. 
The upper airways (nose) and lower airways (lungs) are exposed to dusts when 
the individual breathes, and there are several defence mechanisms to keep the 
mucosal surfaces free from deposited particles. Should be ENM able to escape 
or alter defence mechanisms, they may induce local toxic effects. The phagocytes 
which are cells involved in cleaning body cavities, may be targets of exposure to 
nanomaterials (Geiser and Kreyling, 2010). Oxidative injury, inflammation, fibrosis, 
cytotoxicity and inflammation mediator release have been reported to be the main 
effects after inhalation exposure to fibrous asbestos (Nel et al., 2006), and in vivo 
–studies have shown that the high aspect ratio CNT induce inflammation, fibrosis 
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and mesothelioma (Poland et al., 2008; Ryman-Rasmussen et al., 2009; Takagi et 
al., 2008). A long-term study in mice also indicated that SCNT could cause more 
extensive fibrosis in lungs than asbestos fibres (Shvedova et al., 2014). It remains 
unclear whether ENM are able to cross the air-blood barrier to be translocated to 
other sites of the body or induce systemic inflammation (Castranova, 2011). 
Dermal exposure to ENMs occurs mostly through application of cosmetic 
products and sunscreens as well as in the occupational settings (Elsaesser and 
Howard, 2012). Metal oxide nanoparticles TiO2 and ZnO are used in the cosmetics 
and sunscreens. These nanoparticles are often coated in order to change the surface 
properties of the NP and to minimise their reactivity. Several studies suggest that 
NP cannot pass through intact skin because of the unique layered structure of skin. 
However, if skin is damaged by mechanical injury, ultraviolet (UV) -radiation or 
allergic inflammation, translocation to deeper layers of skin may occur. Then they 
may be engulfed by phagocytic cells and to end up in the regional lymph nodes, or 
travel in the blood circulation to distant organs. Cytotoxicity, inflammatory response, 
possible accumulation into the skin, metabolism and phototoxicity are all important 
areas to needing to be evaluated when assessing dermal toxicity (Tsuji et al., 2006). 
gI-tract may also be a route for ENM to the body especially when they are being 
used in the food products, water and pharmaceuticals (Shi et al., 2013). Inhaled 
ENM may also be swallowed once mucociliary escalator cleared them from the 
respiratory tract. It remains unclear whether ENM are absorbed from the gut and 
translocated to systemic circulation and distribute to other sites of the body (Powell 
et al., 2010). ENM may also induce a local inflammatory response in the GI-tract 
(Medina et al., 2007).  However, in vivo –studies suggest that most ENM in gI-
tract are rapidly discarded via faeces.
3.5 tARget oRgAns
If ENM gain access to the circulation, they may exert effects in the blood vessels or 
end up to other organs (Kettiger et al., 2013). The distribution of ENM to organs 
depends on the site of translocation into the blood stream. Furthermore, if ENM 
tend to agglomerate, they may also cause an embolism in the blood circulation which 
is a serious health concern.  ENM can be distributed to all sites of body, such as 
liver, spleen, kidneys, heart, brains and central nervous system and they may travel 
through placenta (Pietroiusti et al., 2013). The most important factors that influence 
ENM targeting of organs are their size, shape and their surface functionalities but 
also the cells of the translocation site affect on the outcome (Albanese et al., 2013). It 
has been speculated that spherical particles are taken up more rapidly than fibrous 
materials, and that the most efficiently uptaken particles will have a diameter of 
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30 – 50 nm. This knowledge can be utilised in the development of nanotechnology-
based drug carriers. In addition, the effects of ENM on platelet activation and 
thrombus formation as well as the effects of ENM on the microcirculation have 
been studied in vivo. Investigations into engineered nanomaterials showed that 
SCNT could interfere with platelet function and cause pro-thrombic effects on 
microcirculation whereas diesel exhaust and titanium dioxide did not have any 
effects on the blood vessels (Bihari et al., 2010). The effect of different ENM in blood 
vessels and their distribution to distant organs has to be studied more extensively 
in the future.
The positive or negative effects induced by ENM are modified by protein corona 
formation (Kettiger et al., 2013, Tenzer et al. 2013). The attachment of biomolecules 
on the material surface is shown to be dependent on multiple factors such as material 
size, shape, chemical composition and surface charge. Furthermore, the absorption 
of biomolecules, such as proteins, to their ENM surface depends on the type of 
biological fluid with which they are surrounded (Tenzer et al., 2013). The ENM route 
of entry to the body modifies the biomolecular layer in the ENM surface, and this 
protein corona may be responsibe for the true biological identity of ENM. The protein 
corona may enhance the ENM uptake into the cells, induce their active or passive 
transport through body barriers and cause interactions with cellular components. 
This may lead to toxicity in exposure routes themselves or in the translocation sites 
of ENM (Pietroiusti et al., 2013). Therefore, the material-protein binding studies 
will need to be included into the hazard assessment of ENM.
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4.1 PRinciPle
Risk is a combination of the hazard and the exposure, and therefore risk assessment 
(RA) is divided into different phases. Different organisations, such as European 
Chemicals Agency (ECHA) and World Health Organisation (WHO) describe the 
process in somewhat different ways but the purpose is the same: To ensure chemical 
safety. Hazard and exposure assessment are essential for the analysis of risk, and 
risk management is a regulatory process intended to minimise the risk (WHO/IPCS 
2010; ECHA 2011, ECHA 2012). RA may lead to the development of guidance values 
for chemical residuals e.g. in food, to setting of exposure limits for occupational 
exposure and even restriction of use of a substance. The simplified schematic flow 
of the RA process used in both substance and product evaluation is represented 
in the Figure 4.1.
figure 4.1. A schematic flow of risk assessment process.
Hazard assessment is the process where a specific chemical hazard is identified 
and one analyses its potential to cause toxic effects on humans (ECHA 2011). The 
identity of a chemical is determined by evaluation of existing safety data. When 
possible, the quantitative structure-activity relationship (QSAR) data is analysed 
in silico, data from in vitro and in vivo studies is evaluated according to the 
current RA paradigm. If any epidemiological data is available, it can be taken into 
account in the hazard and risk assessment at chemical. The in vivo –data forms 
a basis of hazard identification, however, public pressure to limit unnecessary 
animal suffering, and this has been taken into account in REACH (Registration, 
Evaluation, Authorisation and Restriction of Chemicals) legislation (1907/2006/
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EC) by promotion of development of alternative methods for the hazard assessment. 
In addition to this, the main aims of REACH Regulation are to ensure the high 
level of protection of human health and environment and to improve industrial 
competiveness and innovation potential by unifying means of hazard assessment 
in the EU level. REACH requires authorization of chemicals produced more than 
1 tonnage, and if a chemical poses a risk for human health or environment, it may 
not be authorized or it will be added to Annex XIV. Substances in Annex XIV are 
to be replaced when safer alternatives for the same use are available.
In the Globally Harmonized System of Classification and Labelling of Chemicals 
(GHS; UNECE 2010) specific criteria on hazard classification as well as guidance 
on labelling and for safety data sheets (SDS) have been adopted in order to 
improve hazard communication. gHS also describes the endpoints required to 
the human health risk assessment, such as acute toxicity, skin corrosion/irritation, 
carcinogenicity, respiratory sensitization and toxicity to reproduction, and these 
effects can be further categorised by a chemical’s potency to induce toxicity 
(WHO/IPCS 2010). Toxic endpoints are studied with specific and validated test 
guidelines (Tg) for chemicals such as Tg provided by OECD or with other suitable, 
justified methods. The quantitative or qualitative description of a chemical’s hazard 
characteristics is performed with the results obtained from these studies. In addition, 
the hazard assessment should include the identification and description of mode of 
action (MoA) for critical steps in toxicity such as clarifying molecular and cellular 
pathways (ECHA 2012). Table 4.1 summarises the most common abbreviations 
used in the risk assessment.
The human contact with a potentially hazardous chemical as well as exposure 
route, length and volume of exposure are evaluated in the exposure assessment 
(WHO/IPCS 2010). Different scenarios are available to routinely calculate exposure 
of different groups, like adults or infants via possible routes, such as food, cosmetics 
or toys based on the chemicals concentration on the items and on the estimated 
exposure route and length. Certain parameters, for example human body weight, are 
set to represent the average person, in the exposure assessment calculations. REACH 
legislation provides guidance by describing exposure scenarios in attempts to 
improve the control of risk (ECHA 2007). In addition, if there are known biomarkers 
of exposure, they may be measured from biological samples such as blood and urine 
and utilised in the exposure assessment calculations. With knowledge of hazard and 
exposure parameters, the risk can be characterised by comparing calculated human 
exposure levels to delivered guidance values. Then, risk prevention by personal 
protection, risk mitigation measures and risk communication can be utilised as a 
tool of risk management. 
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table 4.1. The description of the common abbreviations used in the risk assessment (ECHA, 2013).
Abbreaviation Meaning Use
ADI Acceptable Daily 
Intake
An amount of specific chemical that can be ingested on 
a daily basis during the lifetime without a health risk, e.g. 
food additives.
DNEL Derived no-effect 
level
An amount exposure of a specific chemical that above 
humans should not be exposed. In REACH, DNEL 
determination is required for chemicals produced 10 
tonnes or more per year.
MoA Mode of action Functional of anatomical change in cellular level resulting 
from the exposure to the chemical.
NOAEL No observed 
adverse effect level
The highest dose of chemical that is not causing any 
adverse effects in the testing organism.
OECD TG OECD test 
guidelines
A collection of internationally agreed test methods used 
by government, industry and independent laboratories.  
OECD TG are used to determine the safety of chemicals 
and chemical preparations.
SDS Safety data sheet SDS is intended to provide people procedures for 
handling or working with that chemical in a safe manner. 
Requirements are escribed in REACH article 31.
TDI Tolerable daily 
intake
An amount of a chemical that can be ingested on a daily 
basis during the lifetime without a health risk. TDI is 
used in the case of a specific chemical that is not used 
intentionally in food, e.g. contaminants.
WOE Weight of evidence WOE is seldom definied. The most common use is a 
general concept to summarize, synthesize and interpret a 
body of evidence.
4.2 chAllenges with nAnomAteRiAls
Nanomaterials may fall under different regulations in the EU area, such as REACH 
(1907/2006/EC), even if ENM are not referred in Regulation 1907/2006. However, 
as REACH deals with substances in whatever size, shape and chemical composition, 
ENM are covered by REACH. More specific product type regulations refer ENM 
such as biocide (528/2012/EU), plant protection products (1107/2009/EC) or 
pharmaceuticals regulation (726/2004/EC). These legislations strive to safeguard 
and guarantee the appropriate use of different chemicals, and provide regulation 
for placing products into the market and use of the products.  
The greatest challenge in ENM risk assessment and management is the diversity 
of materials and the lack of requirements for the material characterization (Krug and 
Wick, 2011). Since the material characteristics drastically affect their toxic properties 
such as their capacity to deposit to the different regions of lungs, enter to the systemic 
circulation or cross biological barriers, a specific guidance for characterization 
requirements should be provided. For example size, shape, and surface chemistry 
data should be provided when nanotoxicity results have been published to make 
it possible to identify which physico-chemical characteristics are associated with 
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toxicity (Hristozov et al., 2012). In addition, those ENM properties important to the 
identification of specific nanomaterial rather than to the characterization should be 
recognized (OECD, 2013). Furthermore, it is important to document the behaviour 
of the materials in the suspension and their tendency to form agglomerates or 
aggregates. The OECD has published a ‘Guidance on sample preparation and 
dosimetry for the safety testing of manufactured nanomaterials’ to unify material 
handling protocols to be used in the nanosafety testing. However, it will take time 
to set up the protocols in the different laboratories (OECD, 2012).  As risk is also 
dependent on the route of exposure, the material-specific exposure routes and doses 
will need to  be identified (Krug and Wick, 2011). In REACH, is is suggested that 
substances identified by their chemical composition may need to be further identified 
by additional identifiers, such as characterization data (1907/2006/EC). The ENM 
separation from bulk-form of the same chemical composition is challenging, even if 
it is stated in REACH that material ‘sameness’ has to be analyzed by the comparison 
of physical properties, not by comparing the chemical composition. Nevertheless, 
traditional approaches to RA using physico-chemical properties as a predictor of 
toxicity do not seem to be suitable for the RA of ENM, and the utilization of high-
throughput screening approaches for the identification of materials characteristics 
associated with the hazard is in progress (Nel et al., 2013). Also, the adjustments for 
the information requirements in REACH (1907/2006/EC) are to be performed to 
assess ENM behavior and effects on individuals, and to develop new, nano-relevant 
exposure scenarios as well as risk management measures.
The huge number of different forms of ENM being used by different industries 
poses a challenge for traditional RA requirements (Hristozov et al., 2012). There are 
pressures to reduce the numbers of animals used in the chemical hazard evaluation, 
and therefore new protocols for chemical testing in vitro or the evaluation of QSAR 
in silico are required (1907/2006/EC). In vitro –studies can be utilized in the 
identification of hazard mechanisms to understand and recognize the pathways 
activated by the ENM, and to predict the toxicological outcome (Hristozov et al., 
2014b). An awareness of MoA associated with physico-chemical properties of 
material could also help in the grouping of materials which then could be used in 
the extrapolation to other related compounds in their hazard characterization (Nel 
et al., 2013).   However, animal testing is still and will be an essential part of the 
hazard evaluation of ENM: Chronic studies are required and in vivo –studies are 
essential for validation, verification and bridging cell experiments with systemic 
results and to extrapolate exposure-dose –response (Nel, 2013). Building data bases 
by sharing data of physico-chemically and toxicologically (in vitro) characterized 
nanomaterials would enable the use of a systems biology approaches for large 
data sets, and this is hoped to eventually lead to a better understanding of key 
elements in nano hazard identification (Hristozov et al., 2014b; Nel et al., 2013). 
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However, the lack of benchmark or reference materials to different testing protocols 
in nanotoxicology poses a challenge in the evaluation of the quality of data and to 
the validation of test methods (Nel et al., 2013; Schrurs and Lison, 2012). 
To conclude, the main challenges in the hazard assessment of ENM are the large 
number of materials which need to be evaluated case-by-case (Hristozov et al., 2012). 
This is time consuming and expensive and has high requirements since hazard 
assessment is based on in vivo –testing, and current RA protocols may require 
modification, regarding both test methods for the identification of hazard and 
exposure assessment. Different approaches to be used, i.e. ENM grouping, hazard 
scanning, QSAR evaluation, testing of toxicological potency in vitro or predictive 
toxicological modelling, have been suggested, however, there are knowledge gaps 
still to be filled before any of the postulated methods can be applied routinely 
(Nel et al., 2013). Furthermore, a quantitative weight of evidence (WOE) approach 
could be utilized to calculate hazard scores from scientific studies (Hristozov et 
al., 2014b). The problem with the WOE approach is that the more data gaps that 
exist in the reporting of study, the more expert judgment is required and thus 
the more uncertain is the final result. This uncertainty has been and is analyzed 
in large international project funded by 7th framework program of EU, such as 
in NANoREg (http://www.nanoreg.eu) and MARINA (http://www.marina-fp7.
eu). However, good quality data collected from scientific research should also be 
taken into the account in the regulatory RA of ENM in order to minimize the costs 
of nanosafety research, and to promote the development of appropriate methods 
for hazard identification and characterization of ENM (Hristozov et al., 2014a). 
According to REACH, a scientific evidence of probable serious effects may lead to 
classification of chemical to the list of substances of very high concern (SVHC) to 
be replaced by suitable alternatives, and this approach may be utilized with ENM 
with an alarming scientific data (1907/2006/EC).
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5 Aims of the study
5 aIms of the study
The safety of engineered nanomaterials is an inadeguately-studied area, and there 
are concerns about the well-being and health of industrial workers handling ENM 
as well as consumers using nano-based products. Therefore risk assessment and 
management of different nanomaterials are important issues. The overall aim 
of this thesis was to study the toxicity of selected nanomaterials, their ability to 
induce inflammatory reactions, the mechanisms behind these phenomena and in 
this way contribute to the development of risk assessment protocols for engineered 
nanomaterials.
The specific aims of this thesis were to:
• Evaluate the ability of different engineered nanomaterials to activate inflammatory 
cascade (I, II)
• Investigate the mechanisms of pro-inflammatory reactions induced by carbon 
nanotubes and compare these with asbestos fibes (A high aspect ratio theory : 
II, III)
• Compare the penetration and effects of different sized ZnO particles on 
diminished skin epithelial barrier with or without allergic inflammation (IV)
• Evaluate how current approach for chemical hazard assessment serves the needs 
of nanomaterial risk assessment (I–IV)
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6 summary of materIals and methods
The materials and methods used in the study are described in more detail in the 
original publications I–IV.
6.1 nAnomAteRiAls And the susPension PRePARAtion  
 PRotocol (i–iv)
The research on the thesis was concentrated on metal oxide NP (TiO2 and ZnO) 
and different CNM. All materials studied and their references are represented in 
Tables 6.1 and 6.2.
table 6.1. Metal oxide (MOx) nanoparticles studied, their basic characteristics and references.
material tio2 tio2(sio2) Zno
size 30-40 nm 10 x 40 nm 20 nm
elements Ti, O Ti, O, Si Zn, O
Product number 5485HT 637262 5810MR
Producer NanoAmor Sigma-Aldrich NanoAmor
references I I I, IV
The protocol for suspension preparation was similar in all studies. First, materials 
were weighed into glass tubes and a stock solution [1000 μg/ml] was diluted in the 
presence of 2% fetal bovine serum (FBS). Secondly, the stock solution was water-path 
sonicated in 30°C for 20 minutes and further diluted to the concentrations used in 
each study. If multiple concentrations were used in the experiments, serial dilutions 
of NM were prepared. Study concentrations were then water-bath sonicated at 30°C 
for 20 minutes before application to the experimental model.
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table 6.2. Carbon nanomaterials studied, their basic characteristics and references.
material carbon black (cb) scnt mcnt
size 14 nm < 2 nm, 1-5 μm 10-30 nm, 1-3 μm
composition C C, traces of Co C, traces of Ni
trade name / 
Product number
Printex-90 900-1351 900-1260
Producer Evonik Industries SES Research SES Research
references II I I
material smcnt tmcnt rmcnt
size 5-20 nm,1- >10 μm 8-15 nm, 10-50 μm > 50 nm, 13 μm
composition C (>99%) C (>99%) C (>99%)
trade name Baytubes C 150 HP MWCNT 8-15 OD Mitsui-7
Producer Bayer Material Science Cheaptubes, Inc. Mitsui&Co
references II II, III II, III
6.2 cell models (i-iii)
RAW 264.7 mouse macrophages (TIB71, ATCC, US), mouse bone marrow derived 
dendritic cells and human primary macrophages were used in the studies. The 
mouse bone marrow derived cells were isolated from balb/c mice (Scanbur, 
Sweden). Briefly, bone marrow was flushed out from mice hind legs, cultured in 
RPMI 1640 media (Invitrogen, UK) with suitable supplements (detailed description 
in the I) and mouse granulocyte macrophage colony stimulating factor (gM-
CSF) for six days before experiments to allow their differentiation into dendritic 
cells. Human monocyte-derived primary macrophages were differentiated from 
leukocyte-rich buffy coats from healthy blood donors (Finnish Red Cross Blood 
Transfusion Service, Finland) by low-speed density gradient centrifugation on 
Ficoll-Paque Plus (Amersham Biosciences, Sweden). The non-adherent cells were 
washed away and adherent monocytes were cultured in serum-free macrophage 
medium (Macrophage-SFM; Invitrogen, UK) supplemented with human gM-CSF 
(BioSource, USA) for 7 days to allow monocyte differentiation into macrophages 
which were then exposed to different ENM (described in II and III).
6.3 the mouse model of AtoPic deRmAtitis (iv)
The mice were epicutaneously treated with phosphate buffered saline (PBS, vehicle), 
bulk-sized ZnO particles (bZnO), nano-sized ZnO particles (nZnO), combination of 
ovalbumin (OVA, 100 μg, Sigma-Aldrich Co, US) and staphylococcal enterotoxin B 
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(SEB, 2.5 μg, Sigma-Aldrich Co, US), and a combination of OVA, SEB and bZnO or 
a combination of OVA, SEB and nZnO under isoflurane anesthesia. The exposure 
mass of ZnO particles was 1.66 mg. The backs of the mice were shaved with an 
electronic razor and tape-stripped by adhesive tape. Exposing agents (V=100 μl) 
were added on the sterile gauze (1 cm2) then secured onto the back skin of the 
mice with transparent adhesive tape twice a week (the first sensitization week). 
After a two week recovery period, the mice were again tape-stripped (the second 
sensitization week), and an identical patch was reapplied to the same skin site. 
Patches were applied twice during the first sensitization week and three times during 
the second sensitization week. Mice were sacrificed and samples collected 24 h after 
the last sensitization. The schematic flow of the sensitization and exposure protocol 
is represented in Figure 6.1.
figure 6.1. Mouse AD model: A Schematic flow of sensitization and exposure protocol. Mouse patching was 
performed with either PBS or combination of OVA (100 μg/patch) and SEB (2.5 μg/patch). Arrows indicate 
days of sensitization. Elicitations were performed with PBS, OVA+SEB or NP alone or with combination 
of OVA+SEB and NP.
6.4 methods
Only a brief description of methods will be provided. All methods utilized in the 
study and their original publications are represented in Table 6.7. at the end of 
this chapter.
6.4.1 cell deAth AnAlysis (i, iii)
Three different assays were used to study cell viability: Trypan blue and Lactate 
dehydrogenase® (LDH) assay for general cytotoxicity and Apoptosis Percentage 
Apoptosis Assay® for apoptosis studies. Trypan blue stains dead cells whereas live 
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cells remain unstained, and the percentage of dead cells was calculated under the 
light microscopy. The LDH assay (Cytotoxicity Detection KitPLUS, Roche, germany) 
was performed and results were analysed according to the instructions given by 
the manufacturer. APOPercentage apoptosis assay (Biocolor Life Sciences Assays, 
UK) was used according to the manufacturer’s instructions and apoptotic cells were 
manually calculated on the light microscopy.
6.4.2 cytokine/chemokine exPRession AnAlysis (i, iv)
Quantitative real-time reverse transcription-PCR (RT-PCR) analyses were performed 
with 7500 Fast Real-Time PCR system (Applied Biosystems, US). RNA was extracted 
using Trisure® Reagent (Bioline, UK) according to reagent instructions. Total RNA 
concentration and purity were determined by NanoDrop ND-100 Spectophometer 
(Thermo Scientific, DE) and complementary DNA (cDNA) was synthesized with 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). The relative 
expressions of a target gene messenger-RNA (mRNA) were analyzed with PCR 
primers and probes were obtained from Applied Biosystems as pre-developed 
reagents (Table 6.4.). The gene expression between different samples was normalized 
to 18S housekeeping gene.
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table 6.4. Mouse primers and probes used in RT-PCR.
Primer Probe reference
CXCL-5 Mm00436451_g1 I
CXCL-9 Mm00434946_m1 I
CXCL-10 Mm00445235_m1 I
IFN-y Hs00174143_m1 IV
IL-1β Mm00434228_m1 I, IV
IL-4 Hs00174122_m1 IV
IL-6 Mm00446190_m1 I, IV
IL-10 Mm00439616_m1 IV
IL-13 Hs00174379_m1 IV
IL-33 Hs00369211:m1 IV
MIP-1α Mm00441258_m1 I
TNF-α Mm00443258_m1 I, IV
6.4.3 cytokine/chemokine secRetion And seRum Antibody AnAlysis  
 (i, ii, iv)
Secretion of cytokines and chemokines to cell culture supernatants (I, II) as well as 
total antibody levels (IV) in the mouse serum was analyzed with standard sandwich 
ELISA and serum levels of antigen-specific antibody levels (IV) were analysed with 
straight ELISA according to the manufacturer’s instructions. All ELISA assays used 
in the study are summarized in Table 6.5.
table 6.5. ELISA assays used in the study.
Cytokine / Chemokine manufacturer reference
Human IL-1α Diaclone, France II
Human IL-1β Diaclone, France II
Human IL-18 Bender MedSystems, Austria II
Mouse IL-13 eBioscience, US IV
Mouse INF-y eBioscience, US IV
Mouse MIP-1α R&D Systems, US I
Mouse TNF-α eBioscience, US I
Total / OVA / SEB specific IgE BD Pharmingen, US IV
Total / OVA / SEB specific IgG2a BD Pharmingen, US IV
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6.4.4 AnAlysis of cell suRfAce molecules (i)
Flow cytometry (FACS Canto II, BD BioSciences, US) was used to study cell surface 
molecules. ENM exposed cells were removed from cell culturing plates, washed 
and stained with different fluorescently labelled antibodies (Table 6.6.). After the 
pre-defined incubation periods, samples were washed, run into the FACS and data 
was analysed with FlowJo software (TreeStar Inc, US). 
table 6.6. Specification of FACS fluorescently labelled antibodies used in Reference I.
antibody fluorochrome Isotype clone
CD1d PE Rat IgG2b k 1B1
CD11c PerCP_CY5.5 Rat IgG2b k M1/70
CD40 FITC Armenian hamster IgM, k HM40-3
CD86 FITC Rat IgG2a k GL1
F4/80 PE_Cy7 Rat IgG2a k BM8
MHCII PE Rat IgG2b k M5/114.15.2
6.4.5 siRnA tReAtment And PhARmAcologicAl blockAde (ii)
Cells were transfected with 200 nM non-targeting control small interfering RNA 
(siRNA) (AllStars Negative Control siRNA, Qiagen, US) and with 50 nM of four 
different NLRP3 target siRNAs (Hs_CIAS1_6, Hs_CIAS1_9, Hs_CIAS1_10, Hs_
CIAS1_11, Qiagen) or 100 nM of two different P2X7 target siRNAs (Hs_P2RX7_1, 
Hs_P2RX7_2, Qiagen) using the HiPerFect Transfection Reagent (Qiagen) 
according to the manufacturer’s instruction one day prior to exposure with ENM 
or asbestos. After 4 h incubation, cell culture media was changed. Pharmacological 
blockade was performed with the cell-permeable cathepsin B inhibitor Ca-047-Me 
(10 μM, Calbiochem, Germany), the cell-permeable reactive oxidative species (ROS) 
inhibitor N-acetyl-L-cysteine (NAC, 10 mM; Sigma-Aldrich, germany) and the P2X7 
receptor inhibitor AZ11645373 (1μM, Sigma-Aldrich). When Abs or inhibitors were 
used, they were added to the cell culture plates 1 h prior to stimulation with either 
the nanomaterials or asbestos.
6.4.6 westeRn blot AnAlysis (ii, iii)
Cell culture supernatants were concentrated by Amicon UItra-15 –tubes, (Millipore, 
US) according to the manufacturer’s instructions. Proteins were separated on SDS-
PAgE at 200 V and transferred onto Immobilon-P Transfer Membranes (Millipore) 
at +4ºC. The unspecific binding was blocked in PBS containing 5% non-fat milk 
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and membranes were incubated with appropriate HRP-conjugated secondary Abs 
(Dako A/S, Denmark). Proteins were then visualized by the Image Quant LAS 4000 
mini quantitative imager (GE Heathcare, Fairfield, CT, US). ImageQuant TL (GE 
Healthcare Biosciences) was used to analyze the intensities of protein bands. The 
antibodies used in the western blot (WB) analysis were anti-IL-1β (II), anti-cathepsin 
B (II), anti-ACS (II) and anti-2AAA (III).
6.4.7 micRoscoPy
6.4.7.1 Light microscopy (I, III)
Light microscopy was used in the cell viability studies as described earlier and in 
the skin histology analysis described in section 4.4.9.
6.4.7.2 Transmission electron microscope (II)
Exposed cells were washed twice with PBS, fixed with 2.5% glutaraldehyde in 
phosphate buffer, and removed from the plate by scraping. Then cells were post-
fixed in 1 % osmium tetroxide, dehydrated and embedded in epon. Thin sections 
were collected on uncoated copper grids, stained with uranyl acetate and lead citrate 
and then examined with a transmission electron microscope (TEM) operating at 
an acceleration voltage of 80 kV (JEM-1220, Jeol Ltd., Japan). 
6.4.7.3 Fluorescent microscopy (II)
ENM exposed cells cultured on cover slides were washed twice with PBS and the 
stained with acridine orange (AO 0,004% in Sorensen buffer, Sigma-Aldrich). The 
cover slides with AO stained cells were washed and placed upside-down onto the 
object glass with a drop of Sorensen buffer. Fluorescent microscopy analysis of slides 
was performed by using a Zeiss Plan Apochromat 40 objective mounted on a Zeiss 
AxioImager microscope (Carl Zeiss MicroImaging GmbH, Germany) equipped with 
an ISIS fluorescent imaging system version 5.1 (MetaSystems GmbH, Germany).
6.4.7.4 Hyperspectral imaging (IV)
To illustrate material penetration to the skin, the Hyperspectral Imaging (CytoViva; 
Aetos Technologies, Inc, AL) illumination and imaging system was used. DAgE-
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MTI Excel Series CCD digital camera and exponent software (DAgE-MTI of MC, 
Inc. IN), was used to localize, illustrate and analyze ZnO particles in the unstained 
4-μm skin sections. All of these components were integrated into an Olympus BX43 
system microscope (Olympus Corporation, Japan).
6.4.8 PRoteomics methods
6.4.8.1 DIGE labeling (III)
Protein concentrations of the samples were determined with BioRad DC Protein 
Assay Kit (BioRad, US) and all samples were treated with ReadyPrep 2D Cleanup 
Kit to remove contaminants (BioRad, US). The samples were then re-suspended 
in DIgE labelling buffer (7M urea, 2M thiourea, 30mM tris-HCl, 4% CHAPS) to a 
final concentration of 50 mg / 20 µl. DIGE labelling was performed according to the 
instructions given by the manufacturer (Amersham CyDye DIGE fluors (minimal 
dye) for Ettan DIGE, GE Healthcare Biosciences, US). 75 µg of protein mixture was 
required, 50 µg for secretome analysis and 25 µg for internal standard. 
6.4.8.2 2-dimensional electrophoresis (III)
SERVA IPg Blue strips 3-10 NL (18 cm, SERVA Electrophoresis gmbH, germany) 
were rehydrated in lysis buffer (7M urea, 2M thiourea, 4% CHAPS, 0.04% 
bromophenol blue) supplemented with 3-10 IPg buffer (gE Healthcare Biosciences, 
US) and DeStreak reagent (gE Healthcare Biosciences, US). A cup loading method 
was used to introduce the proteins to IPg strips. Each IPg strip was loaded with 
proteins labeled with Cy5, Cy3 and Cy2. The final volume of sample was adjusted 
to 120 µl / strip with 2 x lysis buffer supplemented with 2% 3-10 IPG buffer and 
2% DTT. Isoelectric focusing (IEF) was performed with Ettan IPgphor IEF system 
(GE Healthcare Biosciences, US). After IEF, the strips were equilibrated at first 
for 15 min in the mixture of 6M urea, 30% glycerol, 2% SDS, 50mM tris-HCl, 2% 
iodoacetamide, 0.04% bromophenol blue, then for another 15 min in the mixture 
of 6M urea, 30% glycerol, 2% SDS, 50mM tris-HCl, 1% dithiothreitol, 0.04% 
bromophenol blue. Second dimension, separation of proteins according to their size 
by polyacrylamide gel electrophoresis (PAgE), was performed using Ettan DALTsix 
Electrophoresis Unit (gE Healthcare Biosciences, US), with 12.5% reducing gels 
in Laemmli buffer. After electrophoresis, the gels were scanned with Ettan DIgE 
Imager (gE Healthcare Biosciences, US).
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6.4.8.3 DeCyder analysis (III)
DeCyder 2-D Differential Analysis Software v.7.0 (gE Healthcare Biosciences) was 
used for the analysis of scanned gel images and for the statistical testing. Spots with 
≥ |1.5| fold change in expression compared to control, with p-value ≤ 0.05 were 
selected for identification by mass spectrometry
6.4.8.4 Protein identification (III)
gels were silver-stained and selected spots were picked from the gels. In-gel digestion 
was performed and the resulting peptides were extracted as previously described 
(Korolainen et al. 2006). Peptide extracts were dried in a vacuum centrifuge and 
diluted to 2% HCOOH. Each peptide mixture was analyzed by automated nanoflow 
capillary LC–MS/MS using a CapLC system (Waters, US) coupled to an electrospray 
ionization quadrupole time-of-flight mass spectrometer (Q-TOF Global, Waters, 
US). The obtained mass fragment spectra were searched in Uniprot database against 
human entries using in-house Mascot v.2.1 (Matrix Science Ltd., UK). 
6.4.8.5 Bioinformatics analysis (III)
Hierarchical clustering was performed for Cy2 standardized intensity values 
exported from DeCyder with R software version 3.0.0. (R Core team, Austria). 
Differentially secreted proteins were tested by the limma package (Limma, 2013) 
implemented in the bioconductor (gentleman et al 2004). Nominal P-value <0.01 
were considered significant. Information on gene ontology was gathered from Protein 
knowledge base of UniProt (www.uniprot.org) and the KEgg pathway analysis and 
enriched functional domain analysis of identified proteins was performed by DAVID 
Bioinformatics Resources (http://david.abcc.ncifcrf.gov/, Huang 2009). 
6.4.9 histology (iv) 
For histology analysis, tissue biopsies were fixed in 10% buffered formalin and 
embedded in paraffin. 4-μm skin sections were cut and stained with haematoxylin 
and eosin (H&E) for cell counts and to measure epidermal or dermal thicknesses, 
and with o-toluidine blue for mast cell counts. For immunohistochemistry, skin 
specimens were embedded in Tissue-Tek oxacalcitriol compound (Sakura Finetek 
Europe B.V., The Netherlands), frozen and staining of different subtypes of T-cells 
(CD3+, CD4+ and CD8+) and macrophages were performed (detailed description 
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in IV). The sections were examined under light microscopy (Leica DM 4000B, 
Germany). Inflammatory cells were counted from 15 high-power fields (HPF) 
at 1 000 x magnification, mast cells, T-cell subtypes and macrophages at 400 x 
magnification. 
6.4.10 lymPh node stimulAtions (iv)
Cells from draining lymph nodes were collected and cultured in RPMI 1640 with 
suitable supplements in the presence of OVA (50 μg/ml) or SEB (1 μg/ml) for 6 
hours (described in detail in IV). IL-13 and INF-γ ELISAs were used according to 
the manufacturer’s instructions to measure cytokine concetrations from cell culture 
supernatants (see Table 6.5.). 
6.4.11 dAtA AnAlysis (i, ii, iv)
Data were analysed using graphPad Prism 4 Software (graphPad Software Inc., 
US). The statistical tests were selected based on the assay; an unpaired (students) 
t-test or Mann-Whitney U-test was used to compare the differences between the 
groups. Significance levels p< 0.05: *, p<0.01: ** and P<0.001: *** were used. All 
data are represented as means ± standard error (SD).  
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table 6.7. Summary of used methods (original publications indicated).
method reference
Cell culturing
RAW 264.7 cells I
Mouse bone marrow derived DC I
Human primary macrophages II, III
Lymph node restimulation IV
Cell death assays
Trypan blue I
LDH cytotoxicity assay II, III
ApoPercentage apoptosis assay III
Basic techniques in molecular biology
Cytokine/Chemokine expression analysis (RT-PCR) I, IV
Cytokine/Chemokine secretion analysis (ELISA) I, II, IV
Serum antibody analysis  (ELISA) IV
Flow cytometry I
Pharmacological Blockade II
Small interfering RNA treatment II
Western blotting II, III
Microscopy
Light microscopy I, III, IV
Transmission electron microscopy II
Fluorescent microscopy II
Hyperspectral imaging (Cytoviva) IV
Proteomics techniques
DIGE labeling III
2-DIGE III
DeCyder Analysis III
Protein identification III
Bioinformatics analysis III
Histology IV
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7 Results
7 results
7.1 metAl oxide nAnoPARticles (i, iv)
7.1.1 mAjoR diffeRences in the levels of cytotoxicity of diffeRent  
 tio2 And Zno nAnoPARticles (i)
The cytotoxicity of TiO2, TiO2-silica and ZnO NP was studied with mouse macrophage 
cell line (RAW264.7) and mouse bone marrow derived dendritic cells (bmDC) with 
the Trypan blue cell staining assay. Theytotoxicity of different TiO2 NP was studied 
in 30, 100 and 300 μg/ml with a clear dose-response evident with both cell types. 
There was no difference in the levels of occurring cytotoxicity in antigen presenting 
cells in response to the different types of TiO2 particles. In contrast, ZnO NP were 
highly cytotoxic to both cell types, and 100 times lower concentrations were used in 
the experiments.The highest dose (30 μg/ml) was able to induce cell death in >50% 
of both cell types, in contrast mouse dendritic cells were clearly more sensitive than 
mouse macrophage cell line cells to the ZnO induced cell death.
7.1.2 suRfAce modificAtion influences the tio2 nP induced   
 immunotoxicity (i)
The ability of TiO2 and TiO2-silica NP to induce cytokine and chemokine mRNA 
transcription in RAW 264.7 cells and bmDC was studied at two time points, 6 and 
24 h. In addition, selected cytokines were studied at the protein level from the cell 
culture supernatants of NP-exposed cells after 24 h. Overall, the results suggest that 
TiO2-silica is a stronger activator of pro-inflammatory response than uncoated TiO2 
as it induced a high expression of the pro-inflammatory cytokines IL-1β, IL-6 and 
TNF-α as well as the neutrophil attracting chemokine MIP-1α in RAW 264.7 cells. 
Neither uncoated nor coated TiO2 NP induced the expression of studied cytokines/
chemokines in the primary dendritic cells. At the protein level, both TiO2 NP induced 
the secretion of TNF-α and MIP-1α from macrophages; however, the TiO2-silica NP 
induced profound secretion of both proteins in lower doses. The in vitro –analysis 
revealed that TiO2 NP exposed cells had been activated to produce pro-inflammatory 
mediators in both mRNA and protein level, whereas surface treatment of TiO2 
particles may have had a high effect on their potency to activate cells.
In the flow cytometry analysis of cell surface markers, both TiO2 NP induced 
expression of macrophage maturation marker CD11c, antigen presentation markers 
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MHCII and CD1d and co-stimulation molecules CD86 and CD40 in RAW 264.7 cells 
after 24 h exposure to TiO2-silica NP being more potent activator of cells. However, 
after 48 h exposure uncoated TiO2 exposed cells showed greater potency to induce 
expression of these cell surface molecules. These in vitro –experiments indicate 
that both uncoated and coated TiO2 NP had been able to activate macrophages to 
act as the first step in the cascade of pro-inflammatory reaction.
7.1.3 Zno nAnoPARticles ActivAte mAcRoPhAges And dendRitic   
 cells In VITro (i)
ZnO NP evoked a powerful induction of the expression of the pro-inflammatory 
cytokines IL-1β and IL-6 as well as neutrophil-attracting chemokine CXCL-9 in RAW 
264.7 macrophages. In addition to these inflammation mediators, the expressions 
of TNF-α, CXCL-5 and CXCL-10 were induced in bmDC suggesting that a pro-
inflammatory cascade in both important antigen presenting cell types had been 
activated by ZnO NP. Indeed, when studying cell surface markers in RAW 264.7 
cells, the expression of macrophage maturation marker CD11c, T-cell co-stimulation 
markers DC86 and CD40 and antigen presentation markers MHCII and CDid were 
seen after 24 h of exposure with ZnO NP, evident of the potency of nano-ZnO to 
activate inflammatory responses and maturate macrophages, potentially leading 
to decreased capability of phagocytosis.
7.1.4 PARticle siZe modulAtes the inflAmmAtoRy ResPonse   
 In VIVo (iv)
 7.1.4.1 The local allergic reaction is significantly diminished after skin   
 treatment with nano-Zno
Patients with AD have an increased skin thickness and there is infiltration of 
inflammatory cells within skin lesions, and the effect of different sized ZnO particles 
was studied in this phenomenon. The histological analysis of mice back skin revealed 
that both bulk-ZnO (bZnO) and nano-ZnO (nZnO) decreased the thickness of 
skin and the numbers of infiltrating inflammatory cells in OVA+SEB sensitised 
mice, where the suppression of nZnO in the inflammation was stronger than that 
achieved with bZnO. On the contrary, macrophage numbers in the skin histological 
samples were increased in particle-treated groups, suggesting that macrophages 
had been attracted to scavenge the treatment site to seek out particles. This effect 
was independent of OVA+SEB sensitisation and stronger in bZnO treated skin. 
Hyperspectral imaging revealed that both particle types were agglomerated into the 
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skin surface; bZnO were detected from the epidermis of the damaged or allergic 
skin whereas nZnO was found not only from epidermis and hair follicles but also 
from the dermis of the allergic skin. 
Since AD patients have local inflammation in the skin lesions, the effect of ZnO 
particles was studied on the expression of pro-inflammatory, Th1-type, Th-2-type 
and anti-inflammatory cytokines. The analysis showed that mRNA expression of 
important pro-inflammatory cytokines IL-1β, IL-6 and TNF-α was induced in the 
skin.  In addition, expression of Th1 type cytokine IFN-γ, Th2 type cytokines IL-4, 
IL-13 and IL-33 associated with allergy and anti-inflammatory cytokine IL-10 was 
upregulated in the allergic skin. In contrast, if the AD model of allergic skin was 
treated with nZnO, the expression levels of all cytokines studied was significantly 
lower. In addition, the bulk-ZnO showed a similar, but weaker response in the 
OVA+SEB sensitised mice skin tissue but it failed to suppress Th2-type cytokine 
expression in the allergic skin. When cells from local lymph nodes were isolated and 
stimulated with OVA, the production of IL-13 and IFN-γ were strongly increased in 
the OVA+SEB sensitised mice. The protein levels were suppressed if mice skin was 
treated with nZnO but not if the skin was treated with bZnO, however, the level of 
suppression was not statistically significant.
 7.1.4.2 The levels of systemic antibodies in serum are increased after skin   
 treatment with nano-Zno 
Patients suffering AD have elevated levels of IgE antibodies in their blood circulation. 
Therefore, total and OVA or SEB specific IgE and IgG2a levels were measured 
from mice sera. ZnO treatment drastically induced serum IgE levels, both total and 
OVA-specific IgE whereas there was no effect in the total of OVA-specific IgG2a 
levels or in the SEB-specific IgE or IgG2a levels. The induction was more intense 
if mice were locally treated with nZnO than bZnO. These results suggest that both 
bulk- and nano-ZnO induce production of systemic Th2-type antibodies, leading 
to systemic sensitization.
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7.2 cARbon nAnomAteRiAls (i, ii, iii)
7.2.1 shoRt cARbon nAnotubes ARe weAk induceRs of A  
 PRo-inflAmmAtoRy ResPonse in mouse in vitro –cell models (i)
The cytotoxicity of short single-walled (S) and multi-walled (M) carbon nanotubes 
was evaluated in mouse RAW 264.7 cells and primary bone-marrow derived dendritic 
cells. In mouse macrophages, there was no significant cytotoxicity noted with any 
of the doses (30, 100, 300 μg/ml) tested. In DC, dose-dependent cytotoxicity was 
observed, however, there was no difference in the short SCNT and MCNT induced 
response. The expression of different cytokines and chemokines was not induced in 
DC by the treatment of short CNT, and in macrophage cell line short MCNT but not 
SCNT induced MIP-1α mRNA expression and protein secretion. However, no other 
changes were observed. The flow cytometry analysis of RAW 264.7 cells also failed 
to show any induction in the expression of cell surface molecules by the treatment 
of cells with short CNT. These materials seem unable to induce pro-inflammatory 
reactions in the chosen mouse in vitro –cell models.
7.2.1.1 rigid multi-walled carbon nanotubes but no other types of carbon  
 nanomaterials activate profound IL-1 –family cytokine secretion from  
 human primary macrophages (II)
Short MCNT, long and tangled MCNT as well as long and rigid MCNT were studied 
for their ability to induce IL-1 –family cytokine secretion in LPS-primed human 
primary macrophages after 6 h of exposure. Carbon black nanoparticles were used as 
a material control and crocidolite asbestos as a positive control for the experiments. 
The IL-1 –family cytokine secretion is a highly controlled process in macrophages, 
and the expression of pro-IL-1α/ β is not constant. Their transcription is known to 
be activated by Toll-like receptor-4 (TLR4) activation by bacterial lipopolysaccharide 
(LPS), and therefore LPS treatment of macrophages was used prior to exposure 
to carbon nanomaterials and asbestos fibres. The secretions of both IL-1α and IL-
1β were clearly induced by treatment with long, rigid MCNT and asbestos fibres 
whereas other CNM studied failed to activate the secretion. The analysis of IL-18 
displayed similar phenomena. 
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7.2.2 Rigid multi-wAlled cARbon nAnotubes ActivAte then lRP3   
 inflAmmAsome in A similAR mAnneR As Asbestos fibRes (ii)
7.2.2.1 nLrP3 inflammasome activation
The NLRP3 inflammasome regulates the secretion of IL-1 –family cytokines. The 
NLRP3 gene silencing by siRNA treatment clearly achieved a suppression of IL-1β 
secretion after exposure with long, rigid MCNT and asbestos fibres. In addition, the 
WB analysis revealed the secretion of NLRP3 inflammasome component ASC to 
the cell culture supernatant confirming the formation of NLRP3 protein complex.
7.2.2.2 Formation of reactive oxygen species (roS)
The formation of reactive oxygen species has been speculated to be an important 
component leading to the inflammation induced by nanomaterials. It has also been 
shown to be an upstream effector of NLRP3 inflammasome activation. Therefore a 
pharmacological blockade with two antioxidants, APDC and NAC, was performed. 
Indeed, macrophage treatment with both antioxidants prior to rigid fibre exposure 
independently suppressed IL-1β secretion.
7.2.2.3 Leakage of lysosomal contents to the cytoplasm
Cathepsins such as cathepsin B are present in the lysosomal compartment of the 
cells. The lysosomal damage triggers the leakage of cathepsins to the cytosol then 
activating upstream the cascades of the NLRP3 inflammasome complex formation. 
The role of cathepsin B in NLRP3 inflammasome activation after macrophage 
exposure with rigid MCNT and asbestos fibres was studied with cathepsin B inhibitor 
(Ca-047-Me) and with WB analysis of cathepsin B protein from the cell culture 
supernatant. The impaired secretion of IL-1β accompanied with the observation of 
mature cathepsin B was pointing to a role of lysosomal damage in the inflammation 
induced by rigid MCNT.
7.2.2.4 P2X7 receptor activation
Extracellular ATP-gating cation channel P2X7 is an upstream signal for NLRP3 
inflammasome activation. P2X7 allows cations such as K+, to pass through the 
cell membrane leading to NLRP3 inflammasome activation. The silencing of the 
P2X7 gene and pharmacological blockade of P2X7 receptor in macrophages prior to 
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exposure to long, rigid MCNT and asbestos fibres achieved a significant suppression 
of IL-1β secretion, demonstrating that P2X7 receptor activation is an important 
upstream signal for fibre-induced NLRP3 inflammasome activation.
7.2.2.5 Src and Syk tyrosine kinase activation
Tyrosine kinases Src and spleen tyrosine kinase (Syk) are believed to act upstream 
of NLRP3 inflammasome activation. To study whether these pathways are involved 
in fibre-induced NLRP3 activation, a Src kinase inhibitor (PP2) and a Syk-kinase 
inhibitor (SYKII) were administered to the macrophages. Resulting dose-dependent 
inhibition of IL-1β secretion is clear evidence for the involvement of tyrosine kinases 
in the inflammation induced by rigid MCNT and asbestos.
7.2.3 the full PRoteomic PictuRe of Rigid mcnt is moRe similAR to  
 Asbestos fibRes thAn it is to tAngled mcnt (iii)
7.2.3.1 Protein clustering reveals similarities in the macrophage response   
 towards rigid MCnT and asbestos
The proteomics tools were used to analyse the full proteomic picture of secretome 
of macrophages exposed for 6 h with long, tangled MCNT; long, rigid MCNT and 
asbestos fibres. Hierarchical clustering confirmed these results showing similar 
profiles in up-regulated and down-regulated proteins in the secretomes of long, 
rigid MCNT and asbestos fibres whereas long, tangled MCNT showed different 
response. However, the Venn diagram analysis showed that all of the materials 
had a unique set of secreted proteins where long, rigid MCNT had the highest set 
of unique proteins compared to the other treatment groups.
7.2.3.2 rigid MCnT activates signalling cascades leading to cell death 
A bioinformatics analysis of the data collected from macrophages exposed to 
different fibres displayed a protein profile providing evidence that the cell death 
pathway had been activated in macrophages exposed to long, tangled MCNT but 
not with other fibres. Indeed, an analysis of lactate dehydrogenase enzyme from cell 
culture supernatants showed leakage of the enzyme to the supernatant suggestive of 
cellular damage after 18 h of exposure with long, rigid MCNT. In order to confirm 
whether the cells are undergoing necrosis or apoptosis, an apoptosis light microscope 
staining was performed. This suggested that long, rigid MCNT had induced apoptosis 
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in macrophages after 6 and especially after 18 hours of exposure whereas long, 
tangled MCNT and asbestos fibres were incapable of activating this type of cell 
death pathway. David enrichment analysis revealed that all fibres had enriched 
lysosomal pathway suggesting that the particles had been actively ingested to the 
lysosomal compartment of macrophages, however, only rigid MCNT seem to be able 
to induce biological responses associated with lysosomal damage such as apoptosis.
Summary of the effects induced by rigid CNT in human primary macrophages 
is presented in Figure 7.1.
figure 7.1. Rigid MCNT induced P2X7 receptor activation, lysosomal damage, ROS production, Src and 
Syk kinase activation and release of cathepsins in the cell cytoplasm leads to NLRP3 inflammasome 
assembly, activation of caspase-1 and secretion of active IL-1β. Cathepsin release from the lysosomes to the 
cytoplasm also leads to apoptosis and furthermore, caspase-1 activation is speculated to induce pyroptosis 
in macrophages evoking inflammation in the surrounding tissue.
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8 dIscussIon
Engineered nanomaterials (ENM) possess unique specific characteristics, and 
depending on their physico-chemical properties, they may induce different responses 
than their non-nano counterparts in humans (Nel et al., 2013). The most likely 
exposure routes to ENM are via lungs and skin, where body has effective protection 
mechanisms to prevent foreign materials from entering to the circulation (geiser 
and Kreyling 2010). The most sophisticated protective system is called immunity 
and it protects body from invading pathogens and foreign materials, however, if the 
cleavage is not successful, inflammation may become chronic and cause unwanted 
effects (Janeways’s Immunobiology, 2011). In this thesis, the immunotoxicological 
effects of metal nanoparticles and carbon nanotubes were studied in the antigen 
presenting cells (APC), macrophages and dendritic cells, acting as first line of defense 
in the body surfaces, and the mechanisms behind these effects were then further 
investigated. In addition, the atopic dermatitis (AD) disease model was utilized 
to investigate particle penetration and ZnO effects in diseased skin. New insights 
from the mechanisms of toxicity of ENM as well as from the particle penetration 
and effects in the damaged, allergic skin were gained from these studies. According 
to these results, it can be postulated that an immunotoxicological analysis may be 
able to separate hazardous ENM from non-hazardous ones by their mode of action 
(MoA) and should be consireded as one of the first steps in the hazard assessment 
of ENM. As more knowledge is gained from mechanisms of nanotoxicity, it should 
be possible to develop more efficient risk assessment protocols suitable for ENM 
and thus to assure the nanosafety of individuals, especially for the manufacturers, 
importers and the downstream users of products based on nanotechnology.
8.1 toxicity And inflAmmAtoRy effects of engineeRed  
 nAnomAteRiAls In VITro (i-iii)
Engineered nanomaterials with different chemical background have suggested 
inducing different outcomes in both in vitro and in vivo (Wu et al., 2014). Also, 
the ENM modifications, such as size, surface coating and shape influence on the 
hazards posed by to the living organisms (Shi et al., 2013),). The TiO2, ZnO and 
CNT used in the studies induced different results in the cell models used. In the 
mouse macrophages ZnO, was the most cytotoxic material (I), most probably due 
to its ability to release Zn2+ ions (Ng et al., 2013). In the phagocytosing cells such 
as macrophages, the release of this ion may be even higher than in the phosphate 
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buffers, because after digestion the particles are normally located in the highly acidic 
(ph < 4) lysosomes possibly inducing the dissolution of particles. This ‘trojan horse’ 
effect is a well-known pathway of particle toxicity (Studer et al., 2010; Cronholm 
et al., 2013). BmDC were more susceptible to the Zn-effect than macrophages, 
perhaps due to their origin as primary cells rather than immortal cell lines. However, 
ZnO NP showed high cytotoxicity when administered to bmDC even in very low 
concentrations, emphasizing the toxic nature of ZnO NP as compared to the 
other types of ENM studied (Hsin et al., 2008). As different CNT were studied 
(I-III), short SCNT and short MCNT did not seem to induce cell death in mouse 
antigen presenting cells (APC; I) whereas the long, rigid MCNT induced the highest 
cytotoxicity in human macrophages at the late 18 h time point (II-III), whereas other 
types of MCNT were not cytotoxic in human cells. These results suggest that both 
ENM chemistry as well as its surface modifications influence on their cytotoxicity.
When investigating expression of cytokine mRNA in macrophages and DC, 
ZnO and TiO2 induced the expression of different cytokines. However, the levels of 
cytokine TNF-α and chemokine MIP-1α secreted from macrophages were higher if 
the cells were treated with TiO2 than with ZnO, suggesting that ZnO had induced its 
effects via cytotoxic pathways whereas TiO2 may induce pro-inflammatory cascades. 
This speculation is supported by an analysis of co-stimulatory molecule CD86 on 
the surface of macrophages, as TiO2 was the most potent inducer of the cell surface 
marker associated with cell maturation. To compare TiO2 NP with different surface 
modifications, SiO2 coated TiO2 seemed to possess slightly higher potency to incude 
the mRNA and protein levels of pro-inflammatory cytokines and chemokines than 
uncoated TiO2 NP, as was also noted in the cell maturation markers on macrophage 
surface. One can speculate on whether this is a coating effect or whether it is due to 
the different shapes of the TiO2 particles because the uncoated TiO2 was spherical 
with specific surface area of 23 m2/g and SiO2-coated TiO2 particles were more 
needle-like with a more than five times higher specific surface area (132 m2/g). 
The different effects of these TiO2 particles on the inflammatory cascade have been 
further confirmed in vivo (Rossi et al., 2010) but the mechanism behind these 
phenomena remains unclear. In the studies with mouse cells (I), SCNT and MCNT 
did not seem to activate pro-inflammatory reactions in mouse APC, however, both of 
the CNT studied were short and therefore resembled the more carbon black particles 
rather than high aspect ratio nanomaterials (HARN). As investigating HARN (II), 
more precisely long, rigid MCNT, the secretion of the important pro-inflammatory 
cytokine IL-1β was determined, suggesting that rigid MCNT is a potent activator 
of pro-inflammatory cascade in a similar manner than silica crystals and asbestos 
fibers (Hornung et al., 2008). These results greatly reflect data collected from in 
vivo –studies, as ridig fibers have shown to be also more harmful if administered 
by inhalation to mice and rat (Braakhuis et al., 2014).
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8.2 mechAnisms of immunotoxicity induced by   
 engineeRed nAnomAteRiAls In VITro (i-iii)
IL-1 -family cytokine secretion is regulated by NLRP3 inflammasome activation. 
It is known that larger but structurally similar fiber, crocidolite asbestos as well as 
other crystalline materials such as silica and cholesterol crystals activate the NLRP3 
inflammasome by inducing ROS production in macrophages (Duewell et al., 2010; 
Hornung et al., 2008). In our study, it was clearly seen that NLRP3 inflammasome is 
activated after exposure of macrophages with long, rigid MCNT via ROS production, 
lysosomal damage, ATP-gated P2X7 receptor activation and Src and Syk tyrosine 
kinase activation (II). The importance of these pathways in the cytotoxicity and 
inflammation of certain types of MCNT has been shown also in different cell types in 
vitro ((Frohlich, 2013; Singh et al., 2014).). In the investigation of the mechanisms 
behind these phenomena, rigid MCNT and asbestos were identical, supporting the 
high aspect ratio (HAR) theory (Donaldson et al., 2011). Carbon nanotubes may 
differ in their physical identity in many ways: Their length, width, number of carbon 
layers; impurities and rigidity are some of the numerous factors that may influence 
their toxic properties (Lanone et al., 2013), and this study clearly showed that a 
specific fiber-like physical identity is required to activate the pro-inflammatory 
cascade. According to these results, the shape and rigidity of MCNT seems to be a 
key characteristic in the induction of toxicity. It has been speculated that impurities 
such as nickel (Ni) from the manufacturing process of CNT may influence on their 
toxicity (Sohaebuddin et al., 2010), however, as materials used in these studies were 
more than 99% pure carbon, the NLRP3 inflammasome activation is most likely 
not due the residual metals.
Mechanisms of toxicity of MCNT were investigated by using proteomics approach 
(III) to understand the whole picture of secreted proteins. In these experiments 
macrophages were exposed to with long, tangled MCNT; long, rigid MCNT and 
crocidolite asbestos and secretome profiles of macrophages were analyzed and 
compared. This revealed that the secretome induced by rigid MCNT displayed more 
common features with asbestos fibers, however, analysis also showed own unique 
set of proteins for rigid MCNT. They seemed to have a greater ability to induce cell 
death, and that may be pathway exerting the tissue damage seen in vivo (Poland 
et al., 2008; Takagi et al., 2008; Donaldson et al., 2011). The activation of cell 
death cascades may indicate mechanisms of toxicity in the tissues, as cell contents 
released to the tissue may result in excessive local inflammation (Hussain et al., 
2014). However, these results and their importance from a mechanistical view in 
nanotoxicity will need to be validated in further studies which will concentrate on 
comparing the different cell death pathways in different cell types, whole tissues or 
cell co-cultures, and also to evaluate the effects of cell death signalling on neighboring 
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cells (Vandenabeele et al., 2010; Andon and Fadeel, 2012; Joshi and Knecht, 2013). 
The lysosomal damage has been reported as an crucial step of ENM induced 
inflammation (Frohlich, 2012, II), and it can be speculated that fiber-ingestion 
by macrophages leads to leakage of lysosomal contents to cytosol, excessive 
ROS production and either activation of pro-inflammatory cascade by NLRP3 
inflammasome complex formation or to the cell death, leading to release of 
intracellular compartments to the surrounding tissue. On the other hand, the ROS 
production is commonly speculated to be a main pathway to the nanomaterial 
toxicity, and it may be also induced in cell membranes or mitochondria independently 
of lysosomal damage leading also to the non-beneficial outcomes as uncontrolled 
cell death (Fu et al., 2014). However, more studies are required to confirm the 
mechanisms of toxicity and especially the sequence of pro-inflammatory events. In 
the III study, the secretome profile of tangled MCNT resembled more unexposed 
control cells than fiber-exposed cells further confirming the importance of results 
obtained from NLRP3 inflammasome study (II) and suggesting that not all CNT are 
similarly hazardous. These results underline the HAR effect, suggesting that width 
and length –ratio of the MCNT as well as their rigidity determine their toxicity, as 
also revealed in a proteomics study with SCNT in vivo (Teeguarden et al., 2011). 
The evaluation of the importance of NLRP3 inflammasome in the fiber-induced 
inflammation has been confirmed in several studies (Meunier et al., 2012; Yang et al., 
2013; girtsman et al., 2014), and the free radical formation essential for the NLRP3 
inflammasome activation has been shown to be associated with the most toxic fibers 
(Nymark et al., 2014). Therefore, it is evident that this pathway is important in the 
fiber-induced inflammation, however, the importance of P2X7 receptor activation 
and roles of different tyrosine kinases are to be further investigated in the future.
8.3 nAno-siZed Zno PenetRAte into the diseAsed skin  
 And cAuse both locAl And systemic effects
Engineered nanoparticles are widely used as UV-filtering agents in commercial 
sunscreens. Bulk-sized ZnO particles are also commonly used in anti-inflammatory 
pastas commonly applied to the damaged skin, such as into the rash caused by 
nappy usage for babies, as they have antibacterial activity (Fu et al., 2014). It has 
been suggested that different-sized particles do not penetrate healthy skin but 
the phenomena in the diseased skin was unknown (Lin et al 2011). In the mouse 
atopic dermatitis (AD) model (IV) it was clearly shown that nano-ZnO caused 
higher responses than bulk-ZnO. Nano-ZnO penetrated deeper into the layers of 
the damaged, allergic skin, suppressed local inflammation more efficiently and 
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induced extensive production of allergy-associated IgE antibody in the systemic 
circulation. However, if skin was only damaged, not inflamed, nano-ZnO particles 
were not able to penetrate to the deeper layers of the skin. Most probably observed 
effects are mainly attributable to the higher Zn2+ ion release from the larger particle 
surface area (Ng et al., 2013), accompanied by the nanoparticle transport into the 
deeper layers to the skin. In this study, it was clearly demonstrated that size of the 
particle with same chemical composition is an important parameter when assessing 
particle-induced toxicity, which is line with current understanding (Krug and Wick, 
2011; Shi et al., 2013). 
The study indicates that role of allergic inflammation have a great role in the 
particle penetration to the skin. The local inflammation may be caused by sunburns, 
which may in turn influence on particle penetration as sunscreens are commonly 
applied in these situations (Ryser et al., 2014). If observed effects in the AD skin are 
taken together, cell infiltration in the treated skin demonstrate that allergen induced 
skin inflammation is significantly reduced especially by the topical exposure to nZnO 
particles. In contrast, exposure to bZnO increases the infiltration of eosinophils as 
well as macrophages in AD-like skin lesions. This is further confirmed by analysis 
of cytokine expression in the skin, as cytokine levels were downregulated when mice 
were treated with nZnO suggesting that nZnO particles suppress local inflammation 
whereas bZnO failed to suppress Th2-type cytokine expression. As eosinophils are 
known effector cells in the Th2 –type immune response (Spencer and Weller, 
2010), these results suggest that even there are similarities in the particle effects 
on treated skin, there are also differences in the suppression of local inflammation, 
nZnO being the most efficient inhibitor. On the contrary, both sizes of ZnO induced 
antibody levels on blood stream, suggesting elevation of systemic inflammation, 
often associated with topical sensitization to chemcials (Warbrick et al., 2002). 
This phenomenon has to be further studied to understand the full picture of ZnO 
effects via dermal application. However, as UV-light is known to cause malignant 
mesothelioma, it is of importance to use UV-filtering agents, such as nano-ZnO. 
Nevertheless, if skin is damaged and inflamed, the consideration of using protective 
clothing instead of sunscreens may be necessary.
8.4 usAbility of the collected dAtA in the hAZARd   
 Assessment
Nanomaterial hazard assessment is a growing field of science, and a plethora 
of toxicological studies have been published in the last decade (NAS, 2012). 
Nevertheless, the suitability of these studies as tools of risk assessment needs to 
be critically evaluated (Klimisch et al., 1997). In immunotoxicology, the lack of 
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guidelines, common endpoints, benchmark materials and the variability on cell 
types used in the in vitro –studies complicate any comparison of results from 
different studies. In addition, the lack of any consensus in the nanomaterial 
characterization data required for publishing the results increases uncertainty on 
the data assessment. The OECD is providing recommendations for the requirements 
of material characterization for genotoxicity studies (OECD 2014), and these data 
should be equally required from all toxicity screening studies: Primary particle 
size distribution, aggregation and agglomeration state, shape and aspect ratio, 
crystallinity, specific surface area, dispersibility, dustiness (aerosol exposure studies) 
and ENM solubility, and all has to be analyzed in the test media used. In addition, 
in order to make the data comparable, common benchmark materials and doses 
should be set and used to validate the results (Klimisch et al., 1997; Nel et al., 
2013). In this thesis, the first study (I) was a traditional screening study for different 
ENM. The characterization data from ENM was somewhat incomplete, but in fact, 
it highlights rather well that lack of benchmark doses and study guidelines makes 
the data comparison challenging. On the other hand, in the NLRP3 inflammasome 
study (II), both negative and positive material controls were used to improve the 
data quality, but the third study (III) again lacked a negative benchmark material. 
As scientific data quality varies a lot, the careful expert judgement of usability of 
data is required to ensure usability of collected data on hazard assessment (Klimisch 
et al., 1997; Beronius et al., 2013). 
Usually, the term biological identity describes the biomolecules that absorb onto 
the material surface, which is dependent on the route of entry into the body as 
well as on the dispersion vehicle such as cell culturing media (Bhattacharya et al., 
2013; Tenzer et al., 2013). The biological identity of ENM used in the studies (I-IV) 
remains uncharacterized. The status of material agglomeration and aggregation 
remains unclear and it cannot be confirmed whether or not the toxic phenomena 
were due to the single particles/fibers or –more likely- to the larger mass of bound 
particles/fibers. In addition, the status of biomolecule absorption on the material 
surface remains uncharacterized. In a biological system, this depends on route of 
entry, but in in vitro –studies in presence of serum in cell culturing media may 
lead to the formation of a protein corona around the single particle modifying its 
size, reactivity and toxicological properties. It was suggested that protein corona 
formation may differ extensively between different types of TiO2 nanoparticles (Sund 
et al., 2011), and therefore it can be postulated that even if materials may have 
the same chemical identity, their biological identities may be very different, and 
therefore they may induce different toxicological outcomes (Tenzer et al., 2013).
In principle, these results suggest that the use of high-aspect ratio nanomaterials, 
more specifically long, rigid CNT should be avoided due to their high toxicity. 
According to REACH regulation, if the production of these nanotubes would be 
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more than 1 tonnage, the scientific data should be taken into account and either 
not authorize rigid CNT or add it to Annex XIV (substances to be replaced) until 
other types of CNT have been proved to have same characteristics to be utilized in 
the industrial processes. In addition to this, the toxicity data from other types of 
CNT should support the replacement by showing less toxic properties, as suggested 
in II and III.
8.5 futuRe PRosPects
Mechanistical data collected from in vitro –studies may help to recognize certain 
pathways, which are essential for toxicological outcome (Nel, 2013).  The knowledge 
of mechanism of action (MoA) is important in the development of guidelines (gL) 
for toxicity testing, in the material selection and prioritization in the further testing 
of the hazard and to create faster, cheaper and more transparent hazard screening 
processes or to justify the prioritization of certain materials in the first step of 
hazard assessment. 
A successful nanomaterial hazard assessment will most probably be based 
on the development of new tools to achieve an efficient risk characterisation and 
management (Hristozov et al., 2012). However, the evaluation and utilisation of 
existing data are also important (Klimisch et al., 1997). As thousands of differently 
modified materials are being incorporated into the industrial products, occupational 
safety has to be ensured. Since protection protocols are expensive, it would be 
beneficial to be able to differentiate hazardous nanomaterials from their non-
hazardous counterparts (Nel et al., 2013). The communication between basic 
scientists and regulators has to improve, as does the transparency of the processes, 
and the publication bias in i.e. the reluctance of scientific journals to publish negative 
results has to be solved by creating data banks accepting all data as it has emerged 
from well-characterised good-quality studies (Hristozov et al., 2014b). These open-
access databanks could be used for data mining by experts in bioinformatics and 
computational sciences perhaps to develop algorithms which would make it possible 
to recognize appropriate toxicological endpoints and characteristics, and to develop 
a predictive approach for risk assessment to replace the descriptive approach now 
being used by the regulatory authorities (Nel et al., 2013).
The chemical risk assessment process is not simple, and it commonly requires 
expert judgement to set the most suitable risk management measures to minimise 
the possibility of health risks (Beronius et al., 2013; Hristozov et al., 2014b). Existing 
expertise has to be used when developing suitable means to assess hazard and 
exposure for ENM. The suitability of the current practises of classification and 
labelling of chemicals as nanomaterials should also be discussed and, if needed, 
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legislation should be updated according to the knowledge of hazard mechanisms 
in order to ensure nanosafety. 
There will need to be collaboration between toxicologists, computational 
scientists, material chemists, physics experts and occupational hygienists in order 
to develop functional nanosafety approaches. The online-measurements of the 
nanomaterial exposure in the industrial workers would describe the exposure 
and bring new information of the exposure levels in the working places then be 
further utilized in the development of exposure scenarios in the risk assessment. 
Extensive characterisation of material behaviour in different test media would 
help toxicologists to create scenarios for health hazards, eventually to lead to a 
better awareness of the nanorisk. Before the hazard mechanisms of nanomaterials 
are understood, it is only possible to adopt efficient protection measures to avoid 
exposure and treat all ENM as if they were hazardous to human health, even if this 
approach is more costly and slower, because safety comes first. 
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9 concludIng remarks
Nanosafety research is a rapidly growing field, however, the most suitable assays, 
relevant endpoints and detailed requirements for hazard assessment are still being 
debated. The goal of this thesis was to contribute to the assessment of nanohazards by 
producing mechanistical data: By comparing ENM to other types of nanomaterials 
or to their surface-modified, larger or different shaped counterparts in different 
cell models of immunotoxicity or in the mouse skin model of atopic dermatitis.
The results clearly show that each ENM studied has its own unique characteristics, 
which affects on its toxicity. Different metal oxide nanoparticles, TiO2 and ZnO, 
induce different responses in mouse macrophages and dendritic cells most probably 
due to their ability to release free ions from their surface. SiO2-coated TiO2 ENP 
possessed higher potency to activate mouse macrophages in vitro than non-coated 
TiO2 indicating that surface modifications influence their toxic properties of ENP. In 
addition, it was demonstrated that particle size is an important parameter as nano-
sized ZnO particles were more potent suppressors of local inflammation in allergic 
skin in vivo than their bulk-sized counterparts. In addition, nano-ZnO were greater 
inducers of systemic antibodies than bulk-ZnO suggesting that particle penetration 
through damaged, allergic skin and the higher active surface area of the smaller 
particles are relevant in the body’s response to these particles.
The HARN materials have been speculated to induce similar hazardous outcomes 
as asbestos fibres. In this thesis, it was shown that long, rigid CNT could indeed 
activate similar pro-inflammatory pathways in human primary macrophages as 
asbestos fibres. When studying the cellular effects with proteomics tools, the analysis 
clearly showed that complete photographs of secreted proteins of long, rigid CNT 
and asbestos fibres resembled each other even although both materials had their 
unique sets of secreted proteins. More importantly, the other types of CNT studied 
showed no asbestos-like effects, suggesting that not all CNT are equally hazardous. 
Short MCNT or long, tangled CNT did not activate the NLRP3 inflammasome nor 
did the full proteomic picture of long, tangled CNT resemble the secretome of long, 
rigid CNT. These results highlight the mechanisms behind the toxic outcomes of 
certain types of CNT underlining the importance of the development of screening 
assays, which would be suitable for studying these endpoints, especially the NLRP3 
inflammasome activation, in the fibre-induced hazard assessment.
The challenges faced by nanosafety research are the numbers of materials to 
be studied and time and money consuming, animal test –based, risk assessment 
guidelines in chemical testing. Faster screening protocols will need to be developed, 
with improved collaboration between the scientific community, and the regulatory 
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agencies and legislation has to be updated in order to utilise collected data more 
efficiently. Nonetheless, the quality of data has to be ensured; there must be detailed 
material characterisation, and the development of an open-access data bank to 
store high-quality data which will permit computational analysis. In the last decade, 
nanosafety research has been extensively funded and many publications have 
appeared.  Now the scientific community need to find some way to communicate 
their results to the general public. In addition, the regulatory authorities need 
to understand how to improve hazard assessment and characterisation, develop 
techniques to assess exposure to ENM and help to develop new ways of risk 
assessment. 
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